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Abstract 
 
 Mitochondria are essential to the process of cell respiration and 
steroidogenesis. Both of these processes impact the viability of the corpus 
luteum, which is required to maintain early pregnancy. In cattle and other 
species, progesterone supports gestation, regulates embryogenesis and works in 
concert with estrogen to maintain the reproductive tract.  Many investigators have 
sought to understand the processes that control regression of the corpus luteum.  
Two prostaglandins, PGF2! and PGE2, have been implicated in the functioning 
of this transient gland. It is accepted by most researchers that the primary 
luteolysin responsible for functional and structural demise of the corpus luteum is 
PGF2!. However, there is ambiguity between reported effects of PGF2! and 
PGE2 on whole cells and on animals in vivo.  Therefore, the specific effects of 
these prostaglandins on oxygen consumption and progesterone secretion in 
mitochondria isolated from bovine corpora lutea are the focus of this dissertation. 
A decrease in oxygen consumption and a concomitant decrease in ATP may 
contribute to luteolysis. These in vitro studies using isolated mitochondria may 
help to resolve these questions. The first objective was to determine the 
influence of PGF2! and PGE2 on the oxygen consumption of mitochondria 
isolated from bovine corpora lutea. The second objective was to determine the 
effect of both of these prostaglandins on mitochondrial progesterone production. 
This is the first time that the direct effects of PGF2! on mitochondrial cellular 
respiration and steroidogenesis have been studied in the corpora lutea of any 
species. These results will expand information in the area of ovarian physiology 
and may clarify the roles of PGF2! and PGE2 in corpus luteum function. 
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Chapter I.  Introduction 
 Most of our knowledge of reproductive physiology has transpired during 
the past 85 years.  Advances such as artificial insemination, estrous 
synchronization, embryo transfer, in-vitro fertilization, and contraception, to 
mention just a few, have all emerged in the past few decades (Alexander et al., 
2010; Abeydeera, 2002). Now that we have achieved some control over 
reproduction, it has become conceivable to consider optimum population size, 
whether the reference point is the number of cattle or the number of humans 
(Sande et al., 2008; Myrsky et al., 2009). A balance needs to be achieved to 
avoid degradation of the quality of life and the erosion of resources.   
 In 1855 a rapid increase in knowledge led to the beginning of what is 
called modern reproductive physiology. It was recognized that the gonads 
produce steroid hormones that affect reproductive tissues and that the anterior 
pituitary controls the function of the gonads. In the 1940s and 50s the 
understanding of the physiology of sperm led to successful artificial insemination 
of many species.  In the 1960s it became apparent that PGF2 alpha regulates 
the length of the estrous cycle in most mammals (Mellin and Busch, 1976: 
McCracken et al., 1999). Now the cycle could be manipulated to control the  
timing of ovulation. In 1960, the development of radioimmunoassay made 
possible the precise measurement of hormones (Yalow and Berson, 1960; see 
also Yalow, 1978; 1995). The discovery that ovarian stem cells can replenish 
oocytes in postnatal mammalian females is a revolutionary breakthrough.  It 
overturns the belief that oogenesis does not occur in postnatal life. Stem cells in 
the ovary can supply functional follicles in post-natal ovaries. The evidence for 
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neo-oogenesis under normal conditions remains controversial, however. 
Manipulation of stem cells can have tremendous applications in animal 
production (Mooyotto S, 2011).  Despite the multitude of modern advances, 
much remains to be elucidated.  The result of our investigations into the effect of 
prostaglandins on respiration and steroidogenesis will complement and extend 
previously published data on ovarian physiology. 
Primary Reproductive Hormones in the Female 
 Quiescent neurons located in the hypothalamus become active at puberty 
(Plant and Barker-Gibb, 2004).  At the initiation of puberty, gonadotropin 
releasing hormone (GnRH) is produced by neurons in the surge center and tonic 
center of the hypothalamus.  Communication between the hypothalamus and the 
anterior pituitary occurs via a portal system that consists of a capillary bed.  This 
allows minute quantities of releasing hormone to act directly on the cells of the 
anterior pituitary before dilution by the systemic circulation (Charlton, 2008). The 
primary hormones secreted by the anterior pituitary are follicle stimulating 
hormone (FSH) and luteinizing hormone (LH).  Luteinizing hormone targets 
receptors in the theca and follicle stimulating hormone targets receptors in the 
granulosa cells.  After an increase in the secretion of estradiol by the granulosa 
cells, luteinizing hormone peaks, culminating in ovulation and stimulation of the 
corpus luteum to produce progesterone. Progesterone and estrogen have 
important roles in regulating various physiological functions related to growth, 
development, and reproduction in domestic animals.  Recent research suggests 
that these two hormones can alter target cell responses nongenomically via a 
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membrane receptor (Blesson et al., 2012).  Estrogen can suppress LH and 
progesterone, also acting via a membrane receptor and has been shown to 
inhibit binding of oxytocin to its receptors in vitro (Stormshak and Bishop, 2008).   
As the name implies, follicle stimulating hormone causes the growth of 
follicles in the ovary. The neurohormone, oxytocin, is produced in the 
hypothalamus and released from the posterior pituitary, exerting its effects on the 
ovary, uterus, and mammary gland.  Along with estrogen, it is involved in 
inducing the endometrial synthesis of PGF2!, causing regression of the corpus 
luteum (Flint et al., 1986; McCracken et al., 1999).   
Dissertation Chapters 
 Chapter 1, Introduction, lists the primary topics discussed in succeeding 
chapters and includes a review of the literature. The morphology of mitochondria, 
their involvement in corpus luteum function, their role in apoptosis, 
steroidogenesis and respiration is discussed in Chapter 2. In Chapter 3 the  
biosynthesis of prostaglandins is examined, as well as their interaction with nitric 
oxide, endothelin -1 (ET-1), and oxytocin in contributing to luteolysis . In addition, 
in Chapter 3 the effect of PGF2! and PGE2 is emphasized, since our 
investigation is concerned with the influence of these two prostaglandins on 
progesterone synthesis and their effect on luteal cell respiration.  Cholesterol and 
its conversion to steroid hormones is discussed in Chapter 4, which includes 
various enzymes involved in steroidogenesis and the importance of steroidogenic 
acute regulatory protein (StAR) and translocator protein (TSPO) in the entrance 
of cholesterol into the mitochondria. Chapter 5, focuses on respiration and the 
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locus where known inhibitors of the process act. Chapter 6 contains statements 
of our hypothesis and objectives.   Materials, methods, and statistical analysis 
are the subject of Chapter 7.  Chapter 8 summarizes our results and conclusions, 
including the effects of PGF2! and PGE2 on luteolysis. 
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Part 1 
 
Review of the Literature 
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Chapter II.  Mitochondria  
Historical Review 
The earliest records of structures which probably represent mitochondria 
are found in the 1840s (Henle, 1841; Retzius, 1890).  This is only a few years 
after the cell nucleus was discovered.  Altmann, in 1890 was the first to realize 
that these “bioblasts” could be organisms living inside cells that are capable of 
performing important functions.  The name “mitochondrion” was first used in 
1898 by Benda and originates from the Greek word for thread, “mitos” and 
granule, “chondros”.   
 In 1925, Keilin discovered the cytochromes, leading to the conclusion that 
the respiratory chain was a sequence of enzymes with the dehydrogenases on 
one end and an iron-containing respiratory enzyme on the other end (Keilin, 
1925).  Several experiments in the late 1930s uncovered the reaction pathways 
of aerobic respiration. In 1937 Sir Hans Krebs (Krebs and Johnson, 1937) 
described the biochemistry of the citric acid cycle. In 1939 Belitser and 
Tsybakova found that two molecules of ATP are formed per atom of oxygen 
consumed.  These experiments led to the speculation that phosphorylation 
probably occurs as part of the respiratory chain.  In the late 1940s, Friedkin and 
Lehninger verified the supposition that the respiratory chain and phosphorylation 
are linked. It is significant that all these important developments occurred before 
it was known that these intracellular “particles” were mitochondria (James and 
Arney, 1939). Detailed information on mitochondrial ultrastructure awaited the 
development of thin-sectioning techniques in the 1950s. In 1952, Palade 
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discovered that the mitochondrion is surrounded by a membrane which is folded 
into “cristae”. The micrographs of Sjostrand (Sjostrand and Rhodin, 1953) 
revealed a double membrane surrounding the mitochondrion.   
 Research of the past thirty years has strengthened the hypothesis that 
mitochondria are symbionts of a primitive eukaryote (Margulis, 1981).  A more 
recent theory called the serial endosymbiotic theory suggests that a 
protoeukaryotic cell lacking mitochondria evolved first and was able to 
incorporate a proteobacterium by endocytosis.  Transfer of genes from the 
bacterium to the nucleus of the protoeukaryotic cell resulted in the distribution of 
genes, which are currently seen in the two genomes (Gray, 1993; Gray et al., 
1999).  
 Many mitochondrial DNAs (mtDNA) from different organisms have now 
been completely sequenced (Scheffler, 2000).  Most genomes encode proteins 
of Complexes I, III, IV, and Complex V of the electron transport chain.  
Evolutionary studies are now concentrating on the nucleotide sequences of 
specific genes with the intention of further elucidating the evolutionary origins of 
the mitochondria (Scheffler, 2000).  Absolute proof to determine the 
monophyletic versus multiphyletic origins of the mitochondria or to ascertain their 
relationship to present day bacteria may not be possible, because we lack a  
representative of their common ancestral form (Scheffler, 2000). 
Morphology  
 The basic morphology of mitochondria as a matrix enclosed by an inner 
and outer membrane separated by an intermembrane space was revealed when 
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the earliest electron microscope was developed. Transmission electron 
microscopy permitted more detailed views, showing that the inner membrane is 
folded into what are now called “cristae” (Karbowski and Melino, 2003).  
 Decades after this early view was accepted, a revisionist view of the 
mitochondrial membrane is currently being explored (Mannella, 2000; Perkins 
and Frey, 2000). Electron microscopic tomography, which is analogous to 
“computerized axial tomography” (CAT scan), has permitted the reconstruction of 
Leydig cell mitochondria in three dimensions (Prince and Buttle, 2004).  The 
unusual morphology of mitochondria in Leydig cells may be typical of 
mitochondria in other steroidal tissue (Prince, 1999).  In human Leydig cells a 
form of the cristae termed the lamellar association (LA) is apparent. The cristae 
are arranged in apposed layers within the inner mitochondrial membrane, each 
layer separated by a 4 nm gap.  The LA appears to be unique to steroid-
producing cells.  It is surmised that the LA are present in a region of the cristae 
which is not involved in ATP production, since the dimensions do not allow for 
complexes on the matrix side of the cristae.  One of the subunits of ATP 
synthetase is too large to be accommodated in the membrane (Prince, 2000). 
In human Leydig cells, the surface area of the inner membrane is divided 
into two domains.  One domain adheres closely to the outer membrane, making 
contacts with the outer membrane in several locations. This domain has been 
termed the “inner boundary domain”. The second domain of the inner membrane 
forms the cristae, which are now interpreted to form lamellar structures, which 
connect to the first domain of the inner membrane by tubular structures named 
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“crista junctions” (Perkins et al., 1997). In many respects, the structure of the 
cristae is similar to previous studies of nonsteroid-producing cells.  Unique to 
steroid-producing mitochondria, however, is a type of crista in which the lamellae 
are closely applied to each other.  These interconnections form an extensive 
internal membrane system.  This system has an extensive surface area with few 
openings to the inner boundary membrane.  The significance of this form of the 
cristae is unknown (Prince and Buttle, 2004).  
 These investigations into the morphology of the cristae give rise to several 
questions.  Are proteins limited in their distribution between the two domains?  
Does the membrane potential vary from one region of the inner membrane to 
another?  What maintains these two domains of the inner membrane (Scheffler, 
2000)?  A final answer remains elusive (Ernster and Schatz, 1981). 
 Variations can be found in the number, size, and shape of mitochondria 
(Racker, 1970; Tandler and Hoppel, 1972; Novikoff, 1961). Examples of variation 
can be observed in insect flight muscles, where mitochondria are arranged in a 
slab-like orientation (Edwards and Ruska, 1955). In the proximal kidney tubule 
cells and in the flagella of sperm, there is a single, large mitochondrion at the 
base of the cell. Intracellular distribution of mitochondria depends upon several 
circumstances, including cell shape, organization of the cytoskeleton, and energy 
demands of the cell (Sjostrand and Rhodin, 1953). The morphology of 
mitochondria in human oocytes varies from oogenesis through embryonic stages.  
The mitochondria are initially rounded, becoming fewer in number and elongate 
after implantation (Nicholls and Budd, 2000). 
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 Understanding alterations in mitochondria morphology can explain many 
disease conditions.  Abnormal mitochondria cause neuronal synaptic loss and 
cell death in Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease 
(Seo et al., 2010). 
Movement Capability  
Mitochondria are capable of movement.  This is especially apparent during 
mitosis.  However, the significance of these movements is unknown (Frederic 
and Chevremont, 1952).  In 2006, cultured mammalian cells were tagged with 
green fluorescent dye to investigate mitochondrial movement.  Because of the 
diverse roles of mitochondria, their distribution within the cell is of great 
importance.  Lysophosphatic acid, acting via GTPase RhoA, was found to inhibit 
fast movement. Investigators concluded that mitochondrial movement is 
controlled by GTPase RhoA and this control is mediated by formins (Minin et al., 
2006). 
 Interactions of proteins on the outer membrane and components of the 
cytoskeleton, including actin filaments, microtubules, and intermediate filaments  
are involved in movement of the mitochondria (Scheffler, 1999).  An obvious 
problem ensues regarding the equal distribution of mitochondria during cell 
division.  Outer membrane structures identified in yeast suggest that there is 
interaction between cytoskeletal structures and mitochondria in diverse 
cytoskeletal structures in different organisms (Yaffe, 1999). 
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Replication – Fission and Fusion  
 The observation has been made that mitochondria undergo both fission 
and fusion (Bereiter-Hahn and Voth, 1994).  Images of mitochondria that appear 
to be dividing show a septum that can be seen by electron microscopy. 
Components of the outer membrane in yeast lend credence to the idea that 
mitochondria can interact with cytoskeletal structures in different organisms 
(Yaffe, 1999).  Evidence from yeast and fungi support the idea that mitochondria 
form a reticulum or network that is constantly undergoing fissions and fusions.  It 
is known that proteins are continuously mixed and exchanged between 
mitochondria or within the reticulum (Suelmann and Fischer, 2000).   Other 
evidence supports the hypothesis that mitochondria in mammalian cells may 
form an interconnected network that may be involved in the delivery of energy or 
channel calcium between areas of the cell (Frey and Mannella, 2000).  
Mitochondria provide a buffering system, which controls the amount of calcium in 
the cytosol versus the amount required within the mitochondria for the action of 
dehydrogenases in Krebs cycle (Hansford, 1994), a system which may be 
dependent upon a network of microtubules.   
 In eukaryotes, mitochondria may replicate their DNA and undergo fission 
in response to energy needs of the cell.  When energy needs are low, 
mitochondria are destroyed, but if ATP is needed, mitochondria increase in 
number by fission.  A spiral of dynamin forms a helical tube around the organelle, 
constricts when GTP is added, pinching the mitochondrion into two halves 
(Mears et al., 2011). Two mitochondria can also merge into one, a process called 
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fusion.  There appears to be a balance between fission and fusion, but how the 
balance is maintained is unknown. 
Mitochondria are apparently randomly distributed to daughter cells during 
cytokinesis. A daughter cell that fails to receive mitochondria will not survive, 
since mitochondria cannot be synthesized de novo. Their number may be 
increased by fission, but since their genome is uniparental, they will lack 
variation.  Even if recombination occurs, it will not result in greater genetic 
diversity, since an individual’s mitochondrial genes are inherited from the female 
parent.  Although mitochondria in the sperm enter the egg, they are destroyed by 
ubiquitin in the embryo (Sutovsky et al., 1999).  The study of maternal inheritance 
has been useful for divulging the evolutionary history of populations (Lunt et al., 
1997). 
Mitochondria  in the Corpus Luteum  
 Mitochondria are essential for luteal cell function in three ways.  They 
generate most of the ATP required by the cell for energy.  Secondly, they are the 
site of the initial stage of steroidogenesis during which pregnenolone is 
synthesized from cholesterol and subsequently metabolized to produce 
progesterone.  Thirdly, they release pro-apoptotic proteins, e.g. cytochrome c, 
that activates the caspase cascade which triggers apoptosis and programmed 
cell death (Niswender, 2002). 
All three of these mitochondrial roles interact during the life and demise of 
the corpus luteum.  After ovulation the theca interna and granulosa cells of the 
follicle become transformed into luteal cells. This structural and functional 
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remodeling is partially dependent upon the apoptotic capability of the 
mitochondria.  The cells of the corpus luteum synthesize steroids, require ATP, 
and regress to allow the initiation of the next estrous cycle. Mitochondria within 
the corpus luteum initiate steroidogenesis via the production of pregnenolone, a 
portion of which is subsequently metabolized to progesterone, the primary 
hormone produced by the corpus luteum and which is essential for the 
maintenance of pregnancy (Stocco and Sodeman, 1991). All these cellular 
transformative events require energy.  The energy is supplied by oxidative 
phosphorylation within the mitochondria (Niswender and Nett, 1994).  It is logical 
to study the mitochondria and the corpus luteum in concert, since their roles are 
intertwined.  
Involvement of Mitochondria in Cell Respiration  
Cells store and use the energy in the bonds of ATP, which is synthesized 
primarily in the mitochondria.  The first stage of cell respiration, called glycolysis, 
is anaerobic and occurs in the cytosol. The product of this first stage, pyruvate, 
which enters the mitochondrial matrix, is oxidized to acetyl-CoA, which enters the 
second stage, the “citric acid cycle” or “Krebs cycle”. The two products 
synthesized in the second stage, (NADH and FADH2) donate electrons and 
hydrogen atoms which provide energy for the generation of ATP which occurs in 
the third stage (Nelson and Cox, 2005). 
The third and last stage of aerobic respiration, oxidative phosphorylation 
(electron transport chain), is pertinent to our investigation since it culminates in 
the production of the energy-rich compound, ATP. It occurs on the inner 
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membrane of the mitochondria, where enzymes are lined up in an efficient 
sequence. The first protein in the transport chain to receive the electrons from 
NADH (which was synthesized in the Krebs cycle) is an enzyme embedded in 
the membrane, NADH dehydrogenase located in Complex I. A mobile carrier 
called ubiquinone passes the electrons from Complex I to Complex II. Succinate 
enters the transport chain at Complex II and also donates electrons to 
ubiquinone. Complex III, also called the Cytochrome bc1 Complex, passes the 
electrons to cytochrome c.  From cytochrome c, the electrons are passed to 
Complex IV (cytochome c oxidase).  Each passage of electrons is accompanied 
by the expulsion of a proton into the space between the inner and outer 
membrane of the mitochondrion. Hydrogen protons are combined with oxygen at 
Complex IV, producing water (Butterworth PJ, 2005).       
Protons that have accumulated in the intermembrane space enter the ATP 
synthase complex, sometimes designated Complex V.  The parts of this complex 
are arranged in such a way that it resembles a rotary engine.  As hydrogen 
protons enter this structure from an area of high concentration to an area of low 
concentration, the ATP rotator turns, producing the energy for the synthesis of 
ATP from ADP and phosphate (Nelson and Cox, 2005).  ATP is available to 
provide energy for all the processes required to maintain life.  Thus growth and 
function of the corpus luteum are dependent upon the respiratory role of the 
mitochondria 
 State IV oxygen consumption rate (OCR) of the mitochondria is defined 
as in vitro oxygen consumption by isolated mitochondria in a substrate 
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(frequently succinate) in the absence of ADP or any inhibitors. Determination of 
the OCR provided verification that our mitochondria were alive and able to utilize 
succinate as a substrate.  In addition, determination of the OCR allows us to 
ascertain what effect the addition of PGF2! and PGE2 would have on oxygen 
consumption prior to ATP production.   
Involvement of Mitochondria in Steroidogensis 
Steroid hormones are made from cholesterol.  The conversion of 
cholesterol to pregnenolone occurs inside the mitochondria where the cholesterol 
side-chain-cleavage enzyme, (P450scc), resides on the matrix side of the inner 
mitochondrial membrane (Bose et al., 2002; Stocco, 2001).  Thus, P450scc and 
enzymes of the electron transport chain both occupy the inner mitochondrial 
membrane.  It has been shown that P450scc can function only in the 
mitochondria (Black et al., 1994).  Once thought to be the rate-limiting step in 
biosynthesis of steroids, P450scc enzymatic activity is now known to rely upon 
the steroidogenic acute regulatory protein (StAR), which has been localized to 
the outer mitochondrial membrane.  It is StAR which makes cholesterol available 
to the P450scc enzyme (Stocco, 2001; Strauss et al., 1999). A partner in the 
transport of cholesterol is translocator protein (TSPO), which binds to StAR and 
assists in the movement of cholesterol through the outer mitochondrial 
membrane. 
The first two enzymes in the steroidogenic pathway are P450scc and  
3 " hydroxysteroid dehydrogenase (3 " HSD). The latter enzyme converts 
pregnenolone to progesterone and is found primarily in the cytosol.  However, 
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recently it has been located within the mitochondria, inferring that some 
progesterone may be synthesized within the mitochondria as well (Stocco, 2000; 
Chapman et al., 2005).  Earlier evidence that HSD is located within mitochondrial 
fractions of ovarian tissue was reported by Jackanicz and Armstrong, 1968; 
Sulimovici and Boyd, 1969; and Flint and Armstrong, 1971).  Data from these 
investigations confirm that conversion of cholesterol to progesterone can occur 
within the mitochondria of rat and bovine corpora lutea and perhaps within 
mitochondria of other species as well. Further metabolism of progesterone 
occurs in the cytosol of tissue that produces steroids further down the 
steroidogenic pathway, such as glucocorticoids, estrogen and testosterone (Li et 
al., 1997). 
 Several comparisons can be made between respiration and 
steroidogenesis.  First of all, both processes occur on the inner mitochondrial 
membrane.  The manner in which both processes are accommodated on the 
inner membrane is a matter of current speculation.   
The path of electron flow in steroidogenesis involves NADPH and FADH2 
(nicotinamide nucleotides or flavin nucleotides). A series of   oxidation/reduction 
reactions is initiated.  The path of electron flow in steroidogenesis involves a 
compound similar to NADH, NADPH and the same steroidogenic electron 
acceptor, FADH2.  The respiratory electron acceptors carry electrons from 
catabolic reactions to the electron transport chain and the steroidogenic electron 
acceptors carry electrons to anabolic reactions.  Cells maintain separate groups 
of NADH (respiratory electron acceptor) and NADPH (steroidogenic electron 
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acceptor) and these two types of acceptors differ in their capability to perform 
reduction and oxidation reactions.  NADH is found in mitochondria and 
associated with catabolic reactions, e.g. oxygen consumption; whereas NADPH 
is an enzyme complex found in the plasma membrane and associated with 
anabolic reactions.  Both NADH and NADPH decrease the permeability of the 
outer mitochondrial membrane to ADP. Neither can cross the inner mitochondrial 
membrane unassisted. However, the outer mitochondrial membrane is easily 
crossed, since its pores are permeable to molecules smaller than 10 kDa.  Both 
of these electron acceptors are required for the processes of respiration and 
steroidogenesis (Labedzka, 2006).  
Involvement of Mitochondria in Apoptosis  
All cells have a certain lifespan and eventually become candidates for 
what is termed “programmed cell death” or apoptosis.  Apoptotic factors affecting 
the inner membrane necessarily will compromise cellular respiration and 
steroidogenesis.  Mitochondria play an important role in the process, which is 
distinct from necrosis, allowing for the removal of old, damaged cells without the 
destruction of neighboring tissues and permitting the conservation and reuse of 
cell components such as amino acids and nucleotides.  Apoptosis was described 
by Kerr as long ago as 1972 (Kerr et al., 1972).  Morphologic changes during 
embryonic development, DNA damage, viral infections, accumulation of oxidative 
stress (ROS), all require cell death and replacement. The process of functional 
luteolysis requires uterine PGF2!, whereas structural luteolysis requires luteal  
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PGF2! synthesis (apoptosis). A marker of apoptosis is activation of 
endonucleases, which cleave DNA. The appearance of endonuclease activity in 
the CL indicates that apoptosis occurs during luteal regression in cattle (Juengel 
et al., 1993).  There are two apoptotic pathways, but only the intrinsic pathway 
involves the mitochondria, whereas the extrinsic pathway is initiated by 
transmembrane death receptors such as Fas, located on the cell membrane.  
The intrinsic pathway prevails if DNA damage or heat shock occurs.  Ultimately, 
cytochrome c is released by mitochondria and an amplification of the caspase 
cascade is generated (Raff, 1998). 
One early response to stress is an increase in permeability of the outer 
mitochondrial membrane, allowing the release of cytochrome c into the cytosol 
(Labedzka et al., 2006).  In the cytosol, cytochrome c interacts with inositol 
triphosphate (IP3) on the ER, resulting in activation of calcium channels on the 
membrane of the ER.  The sustained increase in calcium creates a positive 
feedback mechanism whereby additional cytochrome c is released from the outer 
mitochondrial membrane (Breckenridge et al., 2003).  
  Pro-apoptotic factors located on the outer membrane, are responsible for 
the change in permeability, which permits the release of both cytochrome c and 
the proapoptotic protein “second mitochondria-derived activator of caspase/direct 
inhibitor of apoptosis-binding protein" (SMAC/DIABLO). If not subject to 
inhibition, SMAC/DIABLO activates caspases (Chai et al., 2000).  
 Caspases are cysteine-aspartic acid proteases discovered in the 1990s 
that are active in necrosis, apoptosis, and inflammation.  Essentially, they cleave 
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cell proteins, resulting in death of the cell.  Caspases are active in both the 
extrinsic and intrinsic pathways of apoptosis.  Once released, cytochrome c binds 
to the “apoptotic protease-activating factor-1”, (APAF-1), causing the formation of 
an apoptosome composed of seven Apaf-1 and seven cytochrome c molecules.  
It is the union of APAF-1 and cytochrome c that forms this large multi-protein 
structure (Cereghetti et al., 2006).  Within the apoptosome, pro-caspase 9 
activates an initiator caspase, turning on a caspase cascade.  Caspase 9 
subsequently activates downstream effector caspases: 3, 6, and 7, thus 
destroying the cells of the corpus luteum from within.  Steroidogenetic activity of 
the mitochondria is therefore compromised. As stated in the chapter on 
respiration, cytochrome c carries electrons between Complex III and Complex IV.  
There should be an awareness that cytochrome c has a completely separate role 
as an instigator of apoptosis.  Since it is a small, water-soluble enzyme, it is 
mobile. When released into the cytoplasm from either the inner mitochondrial 
membrane or the endoplasmic reticulum in response to pro-apoptotic stimuli, it is 
involved in the initiation of apoptosis by binding to an apoptotic protease factor 
(Skulachev, 1998). Thus, the processes of respiration and apoptosis both rely 
upon cytochrome c.  Cytochrome c may be involved in the apoptotic effects of 
PGF2! as well.  Peterson (1988) found that PGE1, PGE2, and PGI2 all 
decreased the synthesis of cytochrome c.  However, PGF2! failed to decrease 
the apoptotic effects of cytochrome c.  Peterson’s study may therefore support 
the luteotropic influence of PGE2 and the luteolytic influence of PGF2!, which 
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has been well documented in numerous studies (Pratt et al., 1977; Fitz et al., 
1993).  
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Chapter III.  Prostaglandins 
 
Historical Review 
 
In1934, prostaglandin was discovered by von Euler of Stockholm during a 
search for adrenaline in animal tissue. The term “prostaglandin” arises from its 
discovery in seminal vesicles from the prostate (Euler 1934, 1936). 
Understanding the characteristics of prostaglandins was hindered by the lack of 
methods to purify lipid-soluble substances.  In 1959 two prostaglandins, PGE1 
and PGF1!, were isolated by Bergstrom and Samuelsson, an achievement for 
which Bergstrom, Samuelsson, and Vane received the Nobel Prize in 1982 
(Bergstrom and Samuelsson, 1965). 
The accepted nomenclature for the prostaglandins assigns letters to 
denote functional groups in the cyclopentane ring.  The subscript numeral 
indicates the number of double bonds, thus the degree of unsaturation.  If the 
hydroxyl group at position 9 in the cyclopentane ring is oriented below the plane 
of the ring, the subscript ! is used; a hydroxyl group above the plane of the ring 
is denoted by " (Zreik and Behrman, 2008; Craig, 1975). 
Biosynthesis 
 Prostaglandins are all derived from arachidonic acid, a 20 carbon 
polyunsaturated fatty acid containing a cyclopentane ring between C8 and C12 
and two side chains (Sun et al., 1977).  The corpus luteum contains abundant 
arachidonic acid (Smith and Dewitt, 1996). Prostaglandins affect every organ in 
the body. They regulate physiological processes such as pregnancy, ovulation, 
luteolysis, and uterine contractions.  Their gastro-intestinal effects include the 
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production of pain, inhibition of acid secretion and stimulation of mucus secretion 
(Ophardt, 2003).   
Cyclooxygenase Pathway  
Arachidonic acid may be metabolized by either of two pathways. One 
pathway oxidizes the substrate via lipoxygenase, resulting in the formation of 
leukotrienes. In contrast, the second pathway begins with the metabolism of 
arachidonic acid by clooxygenase, resulting in the production of prostaglandins 
and thromboxanes (Lands, 1979). Cyclooxygenase-1 maintains normal gastric 
mucosa and influences kidney function, whereas cylooxygenase-2 promotes 
inflammation.  Both of these enzymes are able to convert arachidonic acid to 
prostaglandins, although investigators have reported that cyclooxygenase-1 
(COX-1) requires a higher concentration of arachidonic acid than does 
cyclooxgenase-2 (COX-2) (Arosh et al., 2004) and COX-1 causes platelet 
aggregation, whereas COX-2 produces prostacyclin, which prevents platelets 
from adhering to vessel walls. 
Several enzymes control the production of individual prostaglandins, such 
as cytosolic phospholipase A2 (cPLA2), cyclooxygenases, and prostaglandin 
synthase  (Smith and Dewitt, 1996). Phospholipase A2 initiates the release of 
arachidonic acid from the phospholipids in the cell membrane, exposing it to the 
action of   COX-1 and COX-2.  The action of these enzymes is dependent upon 
the availability of calcium, which activates phospholipase A2. The COXs convert 
arachidonic acid into prostaglandin H2 (PGH2), (Gijon and Leslie, 1999).  
Various synthases catalyze PGH2, resulting in the formation of several 
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prostaglandins, including PGF2! and PGE2.  Both of these prostaglandins use G 
protein-coupled receptors to stimulate target tissue.  These receptors are 
coupled to phospholipase C, giving rise to two second messengers, inositol 
triphosphate (IP3) and diacyl glycerol (DAG).  Inositol triphosphate diffuses into 
the cytosol and liberates intracellular Ca++ (Narumiya and Ushikubi, 1999) and 
DAG remains within the plasma membrane where it activates protein kinase C.  
Results of a study by Wiltbank in 1992 suggest that PGF2! acts via the protein 
kinase C second messenger system to exert antisteroidogenic effects upon large 
luteal cells.  
Various Effects 
The difficulty in investigating the effect of prostaglandins on physiological 
processes is compounded by their transient nature (Lands, 1979).  Degrading 
enzymes in many tissues result in a loss of activity within one circulation of the 
blood (Hansen, 1976; Newcombe, 1975). 
The eicosanoids, a term encompassing both the prostaglandins and 
thromboxanes, readily break down into inactive products.  Thromboxane (TXA2) 
is a vasoconstrictor and platelet aggregator, therefore it is antagonistic to 
prostacyclin (PGI2), which is a vasodilator and inhibitor of platelet aggregation 
(Gryglewski et al., 1976).  The arterial wall, corpus luteum, follicle, and uterus 
produce copious quantities of PGI2 (Bunting et al., 1977).  In vitro PGI2 
production in cardiac tissue is inhibited by nicotine.  It is unclear whether this 
effect is the result of nicotine per se or the action of prostacyclin synthase 
(Wennmole, 1978).  Two other prostaglandins interact antagonistically, but are 
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also capable of similar effects.  PGE2 relaxes smooth muscle of the oviduct, 
whereas PGF2! contracts the muscle of the oviduct (Lindblom and Wikland, 
1982). However, both of these prostaglandins are capable of causing uterine 
contractions, although the threshold concentration of PGF2! required for 
contraction is less than that of PGE2 (Villar et al., 1986). 
Milvae, in Reviews of Reproduction (2000) enumerates the following 
effects of PGF2!:  a decrease in luteal blood flow and decrease in number of 
small luteal cells, altered activity of steroidogenic enzymes, decreased gene 
expression for StAR, increased gene expression of prostaglandin G/H synthase, 
inhibition of steroidogenesis, changes in membrane fluidity, and release of 
oxytocin by the CL.  Conclusions to be drawn from these data are clouded by the 
fact that PGF2! effects vary according to species, culture conditions, and cell 
types.  For example, if PGF2! is added to dispersed bovine luteal cells, it 
actually stimulates progesterone production (Hansel et al., 1991).  Possibly, the 
action of PGF2! is influenced by the presence of endothelial cells (Auletta and 
Flint, 1988) or via the presence of oxytocin (Rodgers, 1990).    
 Although PGs are lipids, they cannot easily cross cell membranes due to 
the presence of charged anions (Schuster VL, 2002). Cellular transporters aid 
their passage through membranes.  These transporters have 12 transmembrane 
domains and are members of the anion transport class of transmembrane 
proteins (Tsai and Wiltbank, 1997). Prostaglandin transporter protein (PGT) aids 
the relocation of PGF2! and PGE2 from the uterus to the ovary via the utero-
ovarian plexus.  Impaired transport of PGF2! could affect luteolysis and fertility in 
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ruminants (Schuster, 1998; 2002; Lee et al., 2010).  Transporter components are 
primarily expressed in the large luteal cells (Arosh et al., 2004). 
PGE2 expresses its effects primarily via the G protein coupled receptors 
designated EP1, EP2, EP3, and EP4.  Recently, it has been determined that EP2 
and not EP4 is the main cAMP- producing PGE2 receptor.  The receptor which 
binds PGF2! is designated the FP receptor  (Arosh et al., 2004). 
 A viable CL and secretion of progesterone is required for maintenance of 
pregnancy in many species.  PGE2 stimulates progesterone as efficiently as 
luteinizing hormone (LH) in both the bovine and ovine according to several 
sources (Weems et al., 2002 and 1997; Kim et al., 2001). PGE2 increases 
progesterone by activation of the cAMP-PKA pathway (Marsh and LeMaire, 1974 
; Boiti et al., 2001). The signaling pathway which leads to luteal regression is 
complicated and differs among species. PGF2! receptor (FP) causes an 
increase in Ca++ and activation of PKC.  Intracellular calcium causes cytosolic 
phospholipase A2 to be activated and targeted to the nuclear membrane, where 
it causes phospholipids in the membrane to release arachidonic acid, which is 
converted to PGF2!.  Activation of PKC also inhibits progesterone production, 
probably by inhibiting StAR protein (Diaz et al., 2002; Anderson et al., 2001; Tsai 
et al., 1998).  
Intraluteal Production 
 A current concept asserts that after the secretion of extraluteal and 
endometrial prostaglandin, luteal sources of prostaglandin regulate the CL (Davis 
and Rueda, 2002).  Investigations of Arosh et al., (2004) suggest that locally 
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produced luteal PGs complement endometrial and extraluteal availability of PG, 
thus influencing the function of the CL.  
 In the large luteal cells (LLC), arachidonic acid is metabolized into PGH2 
by COX-1 and COX-2.  PGH2 is then converted into either PGE2 or PGF2! by  
PGE synthase or PGF synthase.  Prostaglandin transport (PGT) is responsible 
for both the egress and entrance of PGE2 and PGF2! through their receptors.  In 
addition PGT is involved in the transport of PGE2 and PGF2! from the uterus to 
the ovary.  There are ten known PG receptors, but those of importance in luteal 
cells are EP2 and EP3 and FP.   
Both PGE2 and PGF2! have specific roles in the maintenance and 
regression of the CL.  In the bovine, COX-1, PGF synthase, and PG 15-
dehydrogenase are present at constant levels.  However, COX-2, PGE synthase, 
PG transporter, EP2, EP3, and FP levels vary depending upon the phases of the 
corpus luteum.  For example, PGE2 biosynthesis is greater in growing CLs and 
lesser in regressing CLs.  Biosynthesis of PGF2 increases during regression of 
the CL.  Thus, PGE2 is active during the maintenance phase of the CL and 
PGF2! is active primarily during luteal regression. Biosynthesis of both PGs 
occurs primarily in the large luteal cells (Arosh et al., 2004).  
 There is abundant evidence to support the contention that luteal cells 
secrete prostaglandins (Arosh et al., 2004). During early development of the CL 
and during luteolysis, secretion of PGs is elevated.  Several factors are involved 
in this regulation.  In several species an “autoamplification” pathway has been 
identified which enables PGF2! to induce luteal cells to secret additional PGF2!.  
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In various species differing expression of Cyclooxygenase-2 (Cox-2) and 
phospholipase A2 may control the process.  Decreased progesterone, increased 
endothelin-1, as well as increased cytokines, all ensue as a result of PGF2! 
secreted by the CL (Arosh et al., 2004). 
 In the absence of pregnancy, PGF2! from the endometrium initiates 
luteolysis between day 15 and 17 of the 21-day cycle in the bovine  (McCracken 
et al., 1999; Niswender et al., 2000). It has been confirmed by other 
investigations that in ruminants, more than 80% of the total progesterone is 
produced in the large luteal cells independent of any stimulus from LH (Diaz et 
al., 2002; Niswender, 2002).  It remains to be determined why the large luteal 
cells produce the largest amount of progesterone (Niswender, 2002).  In 
ruminants the mechanism responsible for refractoriness of the early CL to PGF2 
is unknown.  It is speculated, however, that limited availability of PG transport in 
combination with increased secretion of PGE2 may explain this refractoriness of 
the early CL to luteolysis. 
Influence of Various Drugs 
The modus operandi of common drugs has been clarified by knowledge of 
the biological activities of the eicosanoids.  Aspirin, the oldest and most common 
drug, inhibits prostaglandin synthesis (Vane, 1971).  Indomethacin blocks the 
cyclooxygenase pathway when administered twice daily on day 4-6 of the 
estrous cycle in heifers (Milvae and Hansel, 1985).  It is speculated that 
prostacyclin may exert a luteotropic effect early in the luteal phase.  
Phospholipase, which acts upon the phospholipids in the cell membrane, making 
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arachidonic acid available, depends upon calcium for eicosanoid synthesis.  
Therefore, agents that inhibit calcium availability, such as local anesthetics, 
reduce prostaglandin production, probably by adversely affecting the 
phospholipase activity (Kunzl et al., 1974).  Acting in a similar manner, 
glucocorticoids inhibit phospholipase A2, thereby decreasing the availability of 
arachidonic acid. This action is probably the reason why glucocorticoids exert an 
anti-inflammatory effect (Kantrowitz et al., 1974). 
Influence of Endothelin-1 (ET-1) 
 Luteal endothelial cells produce endothelin 1, a potent vasoconstrictor that 
interacts with PGF2! to cause luteolysis (Fukada, 1988 and Levin, 1996).  There 
is abundant evidence that endothelin-1 (ET-1) also inhibits steroidogenesis and 
reduces the biosynthesis of both progesterone and prostacyclin (Milvae, 2000). 
Support for this theory is afforded by the discovery of receptors for ET-1 on both 
large and small bovine luteal cells.  Endothelin 1 reaches its greatest 
concentration when PGF2! levels are also increased, at the time of luteolysis, 
lending credence to theory that both ET-1 and PGF2! have a role in luteolysis.  
When ET-1 was administered to ewes, jugular venous progesterone was 
reduced, while the luteal lifespan was not affected.  If ET-1 and PGF2! were 
combined, however, complete luteolysis and a reduction in the lifespan of the CL 
were achieved (Milvae, 2000).  However, ET-1, in the absence of PGF2! does 
not cause luteolysis in cows (Choudhary et al., 2004a) or sheep (Hinckley and 
Milvae, 2001).  
Influence of Nitric Oxide (NO) 
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 Nitric oxide is thought to mediate the luteolytic effect of PGF2! via 
unknown mechanisms. An NO donor (SNAP) when injected directly into the CL 
caused an increase in blood flow (Miyamoto and Shirasuna, 2009).   Studies in 
the cow using the NOS inhibitor, L-NAME, suggest that L-NAME acts by blocking 
PGF2!-induced luteolysis (Jaroszewski and Hansel, 2000).  In 2003, evidence 
supported the contention that L-NAME caused prolongation of the lifespan of the 
CL in heifers and increased progesterone (Jaroszewski, et al., 2003).   
The earliest physiological sign of the luteolytic cascade in the bovine is 
apparent at day 8-12 of the estrous cycle.  At this phase of the cycle, PGF2! 
reduces progesterone concentrations and decreases the volume of the CL.  
PGF2! does not induce luteolysis during the early luteal phase up to day 5 of the 
estrous cycle (Hendricks et al., 1974).  If PGF2 is available endogenously or 
exogenously at day 10, when the CL is mature, there is an increase in blood flow 
at the periphery of the CL, (Miyamoto and Shirasuna, 2009), which is followed by 
a gradual decrease in blood flow (Acosta et al., 2002).  The increased blood flow 
in the periphery of the CL on day 17-18 was accompanied by peak levels of 
plasma 13, 14 dihydro 15 keto PGF2! (PGFM), a metabolite of PGF2!.  
Immediately subsequent to the peak levels of PGFM, progesterone levels 
declined (Miyamoto et al., 2005; Shirasuna et al;, 2008c).  Blood flow in the CL 
increases with each PGFM pulse.  This increased blood flow induced by NO is 
one of the earliest events during luteolysis in the cow (Miyamoto and Shirasuna, 
2009). 
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 The effect of PGF2! and eNOS on the peripheral and central regions of 
the early CL, which is resistant to both PGF2! and luteolysis, was compared to 
the mid CL, which is sensitive to PGF2!.  Although it appears that PGF2! does 
not affect blood flow in the early CL, it is known that PGF2! stimulates the 
expression of eNOS mRNA in the periphery, but not in the center of the mid CL 
(Shirasuna et al., 2008b).  It is hypothesized that PGF2! action depends upon 
the phase of the cycle (early versus midcycle) and also on the region of the CL 
(periphery versus center of the CL).  In conclusion, PGF2! stimulates the 
synthesis of NO which results in increased blood flow in the periphery of the 
mature CL (Miyamoto and Shirasuna, 2009).  Corroborating the conclusions of 
these investigations is an article published in March 2012. The regulation of 
angiogenesis genes by prostaglandin in luteal endothelial cells (ECs) varied 
depending upon the stage of luteolysis.  An increase in prostaglandin on day 11 
of the CL adversely affected blood vessels and reduced hormonal output of the 
CL (Zalman et al., 2012). 
Influence of Oxytocin (OT) 
 In 1906, Sir Henry Dale found that extracts from the human posterior 
pituitary contracted the uterus in a pregnant cat. He named the extract “oxytocin”.  
Forty-seven years after Dale’s discovery, oxytocin was sequenced and 
synthesized by Vincent du Vigneaud (Magon and Kaira, 2011).  Although 
oxytocin exerts multiple effects on various tissues, it is primarily associated with 
hastening labor contractions after distension of the cervix and in causing milk to 
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be released from mammary glands and enter the ducts of the breast after 
stimulation of the nipples (du Vigneaud et al., 1953).  
Oxytocin is a nonapeptide (nine amino acids) synthesized in the corpus 
luteum (McCracken, 1999) and in the supraoptic and paraventricular nuclei of the 
hypothalamus (Ross et al., 2009). It is released into the circulation from the 
posterior pituitary.  In addition to its role in the labor process, it promotes 
generalized feelings of contentment and aids bonding of the infant and mother 
(Meyer, 2007; Marazziti et al., 2006).  
In the bovine CL, the expression of oxytocin mRNA is elevated during the 
early luteal phase (Ivell et al., 1985; Furuya et al., 1990; Wathes and Denning-
Kendall, 1992).  In sheep, oxytocin mRNA is low during the mid to late estrous 
cycle (Ivell et al., 1990).  PGF2! stimulates OT secretion from the CL (Flint and 
Sheldrick, 1982).  Oxytocin stimulates uterine secretion of PGF2! (Roberts and 
McCracken, 1976).  Therefore, there exists a positive feedback mechanism 
between these two hormones. 
Summary of the Effects of ET-1, NO, and OT  
A consideration of current research has led to the proposal of a possible 
sequence of events promoting luteolysis in the bovine.  PGF2! is transported 
from the ovarian artery to luteal microvessels.  PGF2! activates eNOS and the 
peptide apelin in the outer, peripheral area of the CL.  Apelin promotes the 
formation of new blood vessels and the activation of apelin receptors induces the 
release of nitric oxide.  This results in an acute increase in blood flow in the 
peripheral area as a result of vasodilation induced by NO.  The increase in blood 
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flow is one of the earliest physiological signs of luteolysis in the bovine.  After the 
increase in blood flow, PGF2! stimulates the production of endothelin 1 (ET-1) 
and angiotensin II as well as additional PGF2! from luteal cells (Milvae, 2000). 
These vasoactive molecules (NO, ET-1, angiotensin II, and OT) regulate blood 
flow in the CL, thereby expediting luteolysis (Miyamoto and Shirasuna, 2009).  
Apoptotic factors, and perhaps PGF2! as we hypothesize in this dissertation, 
cause the release of cytochrome c from the inner mitochondrial membrane and 
the caspase cascade is generated (Raff, 1998).  The direct relationship between 
PGF2! and release of cytochrome c remains tenuous, but PGF2! had no 
inhibitory effect on the promotion of apoptosis by cytochrome c (Peterson, 1988).   
After the onset of the luteal cascade, there exists a positive feedback between 
PGF2! and OT.  Oxytocin released in a pulsatile manner on days 13-14 in sheep 
induces luteolytic pulses of PGF2!  (McCracken et al., 2012).  The strong 
vasoconstriction which ensues from ET-1, angiotensin II, and OT is accompanied 
by a decrease in progesterone and an increase in apoptosis in both luteal cells 
and endothelial cells.  
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Chapter IV.  Steroidogensis 
Cholesterol  
Steroid hormones are made from cholesterol, a 27 carbon molecule which 
is an important constituent of the cell membrane and a precursor molecule for the 
synthesis of steroidal hormones.  Steroid compounds contain three cyclohexane 
rings and one cyclopentane ring.  Functional groups which attach to this structure 
confer a variety of functions (Heffner and Schust, 2010).   
In 1769, Francois Poulletier de la Salle first identified cholesterol while 
observing gallstones  (Magee, 1998).  The name “cholesterol” originates from the 
Greek word for bile and the word “stereos” for solid, reflecting the fact that 
cholesterol becomes concentrated in the bile and may settle out, forming 
gallstones. 
The major site of cholesterol biosynthesis is the liver.  Twenty to twenty-
five percent of daily cholesterol production occurs in the liver.  Other sites of its 
synthesis include the intestines, adrenal glands, and reproductive organs.  Its 
synthesis is governed by homeostatic mechanisms that depend upon dietary 
intake and liver production.  The greater the dietary consumption of cholesterol 
from animal fat sources, the less the liver will synthesize endogenously (Ness 
and Chambers, 2000).  The primary regulatory mechanism for the synthesis of 
!! "#!
cholesterol is sterol regulatory element-binding protein 1 and 2 (SREBP) 
(Grosshans et al., 2006). This sterol is able to sense the amount of intracellular 
cholesterol in the endoplasmic reticulum of eukaryotes (Espenshade and 
Hughes, 2007).  When SREBP is cleaved, it migrates to the nucleus and 
functions as a transcription factor for intracellular cholesterol in the endoplasmic 
reticulum.  The SREBP pathway regulates the expression of genes that control 
all lipid formation (Eberle et al., 2004). 
Because cholesterol is unique to animals, it is essential for herbivores, 
such as ruminants, to have a cholesterol synthesis pathway.  The first compound 
in the pathway is acetate, from which all of cholesterol’s carbon atoms are 
derived. Synthesis of cholesterol is initiated by acetyl-CoA, an organic compound 
in which an acetyl group is attached to a coenzyme.  Acetyl-CoA is converted to 
hydroxymethylglutaryl-CoA (HMG-CoA) in the cytosol, whereas all subsequent 
steps occur in the smooth ER.  When enzymatically reduced, HMG-CoA 
synthesizes mevalonate.  From this step on, substrates are committed to become 
sterolds.  It is for this reason that attempts to regulate the production of 
cholesterol are concentrated on manipulating the enzyme HMG-CoA reductase. 
Mevalonate, via phosphorylation, produces squalene.  Squalene, in turn, 
synthesizes lanosterol, the first sterol in the pathway.  Lanosterol is the 
immediate sterol precursor of cholesterol (Dayspring, 2008). 
After formation in the liver, cholesterol is concentrated during storage in 
the gall bladder, and then released into the small intestine in response to the 
presence of lipids in the tract. Its chief function in digestion is the emulsification of 
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lipids.  Fifty percent is reabsorbed from the intestine and returned to the blood. In 
addition to excretion as bile, cholesterol may leave the liver as a lipo-protein 
complex called “very low density lipoproteins” (VLDL).  As VLDL circulates in the 
blood, some of the protein moieties may be removed, forming low density 
lipoproteins (LDL).  Lipoproteins have cell-targeting signals that guide the 
transport of cholesterol to its target tissues.  The peripheral tissues obtain most 
of their cholesterol from LDL by endocytosis.  Liver and peripheral tissues 
therefore have two means of obtaining cholesterol:  synthesis from acetyl-CoA by 
the de novo pathway discussed in the preceding paragraph, or they may obtain it 
from the blood via endocytosis.  Dietary cholesterol is converted within the 
intestine to lipid-protein complexes called chylomicrons.  After removal of 
triglycerides from the chylomicrons at the peripheral tissues, remnants of the 
chylomicrons may be taken up by receptors in the liver in a manner similar to the 
uptake of LDL by the liver (Payne and Hales, 2004).  
Cholesterol actually moves back and forth between the liver and 
peripheral tissues.  While LDL removes cholesterol from the liver, high-density 
lipoproteins (HDL) return cholesterol to the liver where excess is excreted as bile 
salts into the intestine.  In this manner, accumulation of detrimental amounts of 
cholesterol may be avoided.  
In addition to its role in digestion, cholesterol is an essential component of 
the cell membrane.  In contrast to plasma membranes, in which cholesterol 
constitutes approximately 20% of the mass of the membrane, in mitochondria it 
makes up about 3% of the mass of the membrane.  Within the cell membrane, 
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the hydroxyl group on cholesterol interacts with the polar head of the 
phospholipids of the membrane.  The hydrocarbon chain of the cholesterol 
molecule is embedded in the membrane in association with nonpolar portions of 
other lipids.  Cholesterol confers fluidity to the membrane and also reduces the 
permeability of the membrane to hydrogen and sodium ions (Rone et al., 2009).  
It accomplishes this feat by separating the phospholipids so that the fatty acid 
chains can’t come together and crystallize.  Because of the way the cholesterol 
molecule is shaped, part of the steroid ring is attracted to the fatty acid tail on the 
nearest phospholipid.  This helps to stabilize the outer surface of the membrane 
and make it less soluble to small hydrophilic molecules.  To function properly, the 
membrane must be neither too fluid nor too firm. Greater firmness is conferred by 
the formation of lipid rafts that associate with larger proteins. A lipid raft contains 
concentrated cholesterol and sphingolipids, a type of phospholipid with longer 
and more saturated fatty acid tails.  These rafts aggregate, making the 
membrane thicker to accommodate proteins which must be in close association 
with other proteins in order to function properly.  Which proteins exist in lipid rafts 
and which do not has not been determined (Alberts, 2002). 
Conversion of Cholesterol to Steroid Hormones 
The conversion of cholesterol to pregnenolone occurs inside the 
mitochondria where the cholesterol side-chain-cleavage enzyme (P450scc) 
resides on the matrix side of the inner mitochondrial membrane (Bose et al., 
2002; Stocco, 2001).  Thus, P450scc and enzymes of the respiratory electron 
transport chain both occupy the inner mitochondrial membrane.  It has been 
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demonstrated that P450scc can function only in the mitochondria (Black et al., 
1994).  Once thought to be the rate-limiting step in biosynthesis of steroids, 
P450scc enzymatic activity is now known to partially rely upon the steroidogenic 
acute regulatory protein (StAR), which has been localized to the outer 
mitochondrial membrane (Stocco, 2001; Strauss et al., 1999).  
The first two enzymes in the steroidogenic pathway are P450scc and  
3!-hydroxysteroid dehydrogenase (3!-HSD). The latter enzyme converts 
pregnenolone to progesterone and is found primarily in the cytosol.  However, 
recently 3!-HSD has been located within the mitochondria, inferring that some 
progesterone may be synthesized within the mitochondria as well (Stocco, 2000; 
Chapman et al., 2005).  As early as the 1960s, it was determined that 3!-HSD 
was located within mitochondrial fractions of ovarian tissue (Jackanicz and 
Armstrong, 1968; Sulimovici and Boyd, 1969; and Flint and Armstrong, 1971).  
Their data confirmed that conversion of cholesterol to progesterone can occur 
within the mitochondria of rat and bovine corpora lutea and perhaps within 
mitochondria of other species as well.  
P450 Enzymes  
 With the advent of the 21st century, our understanding of the identification 
and characterization of the enzymes involved in steroid hormone biosynthesis 
has advanced substantially. Multiple isoforms of 3!-hydroxysteroid 
dehydrogenase (HSD), which is essential for the synthesis of all steroid 
hormones, and 17! - HSD, which is necessary for the final step in biosynthesis 
have been identified and cloned (Schuster et al., 2008). By utilization of 
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alternative promoters, it has been possible to determine the mode of action of 
tissue-specific P450 aromatase, a member of the P450 superfamily, which 
converts androgen to estrogen. Although steroidogenic enzymes are associated 
primarily with the adrenals and gonads, these enzymes have recently been 
identified in the cardiovascular and nervous systems, where they may act in an 
autocrine or paracrine fashion (Payne and Hales, 2004). 
 Although our emphasis in this dissertation is upon those enzymes which 
are important in the biosynthesis of steroids in the gonads, there has been 
evidence in recent years of de novo synthesis in the nervous system and in 
cardiac tissue.  These neurosteroids function as paracrine factors within the 
nervous system in contrast to gonadal and adrenal steroids, which are released 
into the circulatory system to be transported to their target sites.  As new 
techniques become available, it is likely that more peripheral sites of enzyme 
expression will be discovered (Mellon and Griffin, 2002). 
 All the enzymes involved in the biosynthesis of the adrenal steroids: 
corticosterone, cortisol, adosterone as well as those involved in biosynthesis of 
gonadal steroids: progesterone, estradiol, and testosterone, fall into two major 
classes of proteins.  These classes are: the cytochrome P450 heme-containing 
proteins and the hydroxysteroid dehydrogenases.  Isoforms of 3! - HSD are  
homologous in their amino acid composition, unlike the 17! - HSDs that show 
very little amino acid homology (Curnow et al, 1991).  Adrenal and gonadal 
trophic hormones differ in their pathways.  Gonadal hormones act via cAMP 
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through a protein kinase A pathway, whereas adrenal glands use a protein 
kinase C pathway (Tremblay and Viger, 2003; Kuri, 2009). 
 The P450 enzymes (re-named the Cytochrome P450 or CYP) are 
membrane-bound proteins in contact with either the mitochondrial membranes: 
CYP11A, CYP11B1, and CYP11B2 or in contact with the endoplasmic reticulum, 
i.e. microsomal:  CYP17, CYP19, and CYP21. These heme-containing proteins 
are found in bacteria, fungi, plants, and animals (Nelson et al., 1996).  When 
combined in vitro with carbon monoxide, they absorb light maximally at 450 nm.  
The P450s accept two oxygen atoms from nicotinamide adenine dinucleotide 
phosphate (NADPH).  One oxygen atom binds to the substrate as a hydroxyl 
group and the other oxygen atom is reduced to water.  Two distinct electron 
transfer systems are involved in this transfer.   Initially, the mitochondrial transfer 
system passes an electron to adrenodoxin reductase, then to adrenodoxin, then 
to P450 and finally to the substrate.  The microsomal transfer system, which 
takes place in the endoplasmic reticulum, involves cytochrome oxidoreductase, a 
protein which contains two flavins.  In this case electrons are transferred from 
NADPH to a flavinadenine dinucleotide, then to flavinmononucleotide, next to 
P450 and finally to the substrate (Payne and Hales, 2004). 
 CYP11A  (P450scc) 
 CYP11A catalyzes the first step in the biosynthesis of all steroid 
hormones.  Three molecules of oxygen, three molecules of NADPH, and the 
mitochondrial electron transfer system are required.  The side-chain on 
cholesterol is cleaved between carbons 20 and 22, resulting in the C21 steroid 
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pregnenolone (Bose et al., 2002).  CYP11A has been detected in all three zones 
of the adrenals, the theca interna and granulosa cells of ovulatory follicles, 
testes, placenta, central and peripheral nervous systems, and in the human and 
rodent heart (Kaves-Wandover and White, 2000; Young et al., 2001).   
 CYP17 (P450c17) 
 CYP17 utilizes the microsomal electron transfer system of the ER to 
catalyze the hydroxylation of the C21 steroids (pregnenolone and progesterone), 
followed by cleavage of the C17-20 bond, to produce the C19 steroids:  
androstenedione, androgens, and testosterone.  Each reaction requires one 
molecule of NADPH and one molecule of molecular oxygen (Payne and Hales, 
2006).  CYP17 is expressed in Leydig cells and thecal cells, but not in granulosa 
cells (Sasano et al., 1989). 
 CYP19 (P450arom) 
 CYP19 converts the C19 androgens, androstenedione, and testosterone 
to the C18 estrogens, estrone, and estradiol.  Three molecules of oxygen and 
three molecules of NADPH are required for this reaction, which uses the 
microsomal electron transfer system of the ER (Payne and Hales, 2004). 
Regulation and Expression of P450 Steroidogenic Enzymes 
 The nuclear binding protein, steroidogenic factor -1 (SF-1) (Lala et al., 
1992), also referred to as Ad4BP, (Morohashi et al., 1992), is essential for cell-
specific gonadal and adrenal expression of P450 enzymes.  ACTH stimulates the 
release of the adrenal hormones, whereas LH in the theca, corpus luteum, and 
Leydig cells and FSH in the granulosa cells activate adenylate cyclase, thereby 
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increasing cAMP and stimulating the synthesis of P450 enzymes. This 
stimulation is affected via G protein-coupled receptors (Waterman, 1994; 
Waterman and Keeney, 1996).  With the exception of CYP17, whose secretion is 
wholly dependent upon cAMP, other factors aid in maintaining maximal 
expression of the other P450s (Anakwe and Payne, 1987). 
Hydroxysteroid Dehydrogenase 
 One of the chief differences between the P450 enzymes and the 
hydroxysteroid dehydrogenases is the fact that all P450 enzymes are coded by a 
single nuclear gene.  The several isoforms of the 3!-HSDs and the several 
isozymes of 17!-HSDs are each coded by separate genes.  Both the 3!-HSDs 
and the 17!-HSDs are involved in the reduction and oxidation of steroid 
hormones that require NAD+/NADP+. The 17!-HSDs catalyze the final reaction 
in the biosynthesis of estradiol and testosterone. The isomerases are found in 
both mitochondrial and microsomal membranes depending upon the type of cell 
in which they are expressed.  Since they are numbered in the order of their 
discovery, it is not possible to ascribe the same characteristics to similarly 
numbered isoforms found in different species (Simard et al., 1996; Payne et al., 
1997; Ahhaszade et al., 1997). The 3!-HSDs are required for the production of 
all steroid hormones except pregnenolone.   The localization of 3!-HSDs within 
the mitochondria has been determined in bovine adrenal cells and rat adrenal 
cells (Cherradi et al., 1997). The significance of finding 3!-HSD within the 
mitochondria leads to the supposition that some pregnenolone is converted to 
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progesterone before exiting the mitochondria. The HSDs have been studied 
much more extensively in the human, mouse, and rat than in other species. 
 
Intracellular Pathways of Cholesterol Transport 
 The 37 kDa precursor of steroidogenic acute regulatory protein (StAR) is 
synthesized in the cytoplasm, accompanied by chaperone proteins which prevent 
its folding.  In the unfolded form, the precursor is able to gain entrance through 
the outer mitochondrial membrane.  Upon entrance, cleavage of the precursor by 
proteases in the mitochondrion convert the immature 37 kDa form to the mature 
30 kDa form of StAR.   
The presence of a “sterol-binding pocket” on StAR can accommodate one 
molecule of cholesterol when it is in contact with the outer membrane (Miller and 
Auchus, 2011).  When StAR ceases to be in contact with the outer membrane, 
cholesterol transport ceases (Stocco, 2000).  StAR is dependent upon 
transporter protein (TSPO) for its import into the inner membrane (Rone, 2009).    
Translocator Protein (TSPO) is an 18 kDa protein located on the outer 
mitochondrial membrane.  Initially determined to be a secondary binding site for 
diazepam, it was called Peripheral Benzodiazepine Receptor (PBR), a term 
which is still in use.  However, subsequent research has expanded greatly what 
is known regarding its many functions.  It is expressed throughout the body and 
in small amounts in the brain. TSPO is a biomarker of gliosis and inflammation 
associated with several neuropathologic disorders.  Recent investigations 
support the idea that TSPO ligands may act to facilitate healing of brain injury.  In 
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addition, TSPO acts to reduce anxiety and panic attacks without causing 
sedation or withdrawal problems (Chen and Guilarte, 2008).  Upregulation of 
TSPO has been confirmed in multiple sclerosis, Parkinson’s disease, 
Huntington’s disease and Alzheimer’s disease, thus it has been possible to use 
TSPO as a marker to diagnose and follow the progression of many diseases 
(Rone et al., 2009). 
In 1986, TSPO was localized to the outer mitochondrial membrane (Anholt 
et al., 1986). In addition to its association with steroid synthesis in adrenal, 
placental, testicular, ovarian and glial cells (Brown and Papadoupoulos, 2001; 
Papadopoulos et al., 2001; Lacapere and Papadopoulos, 2003; Giatzakis and 
Papadopoulos, 2004), it has a role in such disparate functions as induction of 
apoptosis in colorectal cancer cells, (Batarseh and Papadopoulos, 2010), 
modification of the immune system, regulation of cell proliferation, transport of 
porphyrin.  In addition, it assists the entrance of cholesterol through the outer 
mitochondrial membrane  (Casellas et al., 2002).  A ligand of TSPO, Ro5-4864, 
reduces reactive oxygen species (ROS) cell damage.  Therefore, a beneficial 
effect of this TSPO ligand may prevent aging-associated peripheral nerve 
damage (Leonelli et al., 2005).   
 Of special interest to us is the ability of TSPO to bond with strong affinity 
to cholesterol and to aid in transport of cholesterol across the outer mitochondrial 
membrane  (Papadopoulos et al., 1997).  It is an essential partner with StAR in 
the early steps in steroidogenesis.  There are several steps whereby StAR is 
transferred through the outer membrane and into the inner membrane of the 
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mitochondrion, while TSPO regulates the translocation of cholesterol into the 
inner mitochondrial membrane.  It is unclear how cholesterol binds to P450scc 
after it moves to the membrane (Rone, 2009).   
  Research since the early 2000s has clarified the role of both StAR and 
TSPO. StAR cannot accomplish the transport of cholesterol without the 
assistance of TSPO (Jefcoate and Artemenko 2004).  The outer mitochondrial 
membrane of steroidogenic cells contains abundant receptors for TSPO. These 
receptors have been localized in the mitochondrial permeability transition pore of 
the outer mitochondrial membrane (Marselli et al., 2004), where the receptors 
associate with the porin family of channel proteins.  When porins are activated by 
agonists or acetyl CoA binding protein, their permeability is altered.  Thus, 
mitochondria are able to alter permeability of these channel proteins (Jefcoate 
and Artemenko, 2004). Entrance of cholesterol into the mitochondria may be 
affected by the activity of these porins, since receptors for TSPO are located in 
their vicinity, 
It may be assumed that transport of cholesterol across the aqueous inter-
membrane space occurs with difficulty. This is just one of the many questions 
which require further investigation. The study of the process in yeast has yielded 
some insights, which may be applied to other organisms (Cyr and Neupert, 1996; 
Koehler et al., 2000).  After translation in yeast, immature StAR p37 is 
phosphorylated, causing the enzyme to unfold from its prior conformation.   In its 
unfolded state it is able to pass through channels in the outer mitochondrial 
membrane and inner mitochondrial membrane and refold in the mitochondrial 
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matrix, forming the mature StAR p30.  It is hypothesized that mature StAR p30 
aids the relocation of cholesterol from inner mitochondrial membrane sites which 
are in close proximity to the outer membrane to tubular sites on the inner 
membrane where P450scc is located.  Tubular protrusions and buds can be seen 
on the inner mitochondrial membrane with scanning electron microscopy.  These 
buds increase the surface area, creating more space for steroidogenic enzymes 
and possibly allowing for separation from respiratory domains (Jecoate and 
Artemenko 2004; Riva et al., 2003).  It is further conjectured that stimulatory 
effects of free fatty acids on the metabolism of cholesterol by P450scc may assist 
translocation of StAR to the inner membrane (Dhariwal et al., 1989).  Thus, fatty 
acids may accumulate in proximity to StAR.   
 Many questions remain to be answered by further investigation.  The 
complex process of cholesterol transport is regulated at many points by several 
signaling pathways.  A balance must be maintained between cytoplasmic transfer 
of cholesterol and its transfer into the mitochondria to avoid the accumulation of 
excess cholesterol within the mitochondria. Reference has been made to the 
protein-protein complex involved in cholesterol transport.  A water-soluble form of  
cholesterol, 22-R-hydroxycholesterol, induced pregnenolone synthesis 20-fold 
(Lui, et al., 2006. Questions arise regarding the origin of the cholesterol used in 
steroid synthesis.  It has long been assumed that cholesterol is made available 
via lipid droplets and the plasma membrane.  DiBartolomeis and Jefcoate (1984) 
proposed the presence of pools of cholesterol in the mitochondria that are able to 
support steroidogenesis for the first few minutes.  It is currently thought that 
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these pools can sustain steroidogenesis longer than a few minutes (Lui, 2006).  
Recent technical advances must be brought to bear on other questions.  
Characteristics of the two primary forms of cholesterol, LDL (low density 
lipoprotein) and HDL (high density lipoprotein), vary considerably.  The main 
function of LDL is to transport cholesterol to tissues and arteries, whereas HDL 
transports cholesterol from tissues and arteries to the liver and other organs for 
storage. LDL is a larger compound than HDL and therefore may enter 
mitochondria via endocytosis.  Since Cholesterol in the form of HDL is a smaller 
compound, it may pass into the mitochondria directly bound to esters, 
compounds produced by a reaction between an acid and an alcohol (Maxfield 
and Wustner, 2002).  
 Experiments in yeast suggest that the second messenger, cAMP binds to 
protein kinase A and subunits are released, causing phosphorylation of StAR 
(Cyr and Neupert, 1996; Koehler et al., 2000).  Hormonal signals are thereby 
amplified.  The mechanism whereby amplification occurs is unknown.   A binding 
protein located mainly in the Golgi apparatus (PAP 7) binds to both PKA and 
TSPO.  Li et al., (2001) hypothesizes that PAP7 may be involved in p37 StAR 
phosphorylation. Cholesterol likewise binds to TSPO and enters the inner 
mitochondrial membrane via voltage dependent anion channels (VDAC).  There 
are contact sites between the outer and inner membrane at the location of TSPO 
binding.  Located in the inner membrane is the side-chain cleavage enzyme, 
P450, which cleaves the bond between carbon 20 and 22, removing these from 
the cholesterol molecule and yielding pregnenolone (P).  Failure at any point in 
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this chain of events would prevent the synthesis of pregnenolone and the 
subsequent synthesis of progesterone.  Extrapolation of these data to organisms 
exclusive of yeast should be considered with caution. 
Several comparisons can be made between the processes of 
steroidogenesis and respiration.  First of all, both occur on the inner 
mitochondrial membrane.  The path of electron flow in steroidogenesis involves 
NADPH and FÅDH2 (nicotinamide nucleotides or flavin nucleotides) and a series 
of oxidation/reduction reactions.  The path of electron flow in respiration involves 
a compound similar to NADPH, NADH.  The respiratory electron acceptors carry 
electrons from catabolic reactions to the electron transport chain and the 
steroidogenic electron acceptors carry electrons to anabolic reactions.  Cells 
maintain separate groups of NADH (respiratory electron acceptor) and NADPH 
(steroidogenic electron acceptor).  Neither acceptor can cross the inner 
mitochondrial membrane.  Presumably, they are located in disparate positions on 
the membrane.  The exact location remains to be determined. The inner 
membrane is thus essential for these two processes that have an effect upon the 
corpus luteum: respiration and steroidogenesis. 
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Chapter V.  Respiration 
Overview 
Cellular respiration consists of a series of metabolic reactions that take 
place primarily in the mitochondria for the purpose of converting biochemical 
energy from nutrients into adenosine triphosphate (ATP), releasing carbon 
dioxide and water as waste products.  Cells store and use the energy in the 
bonds of ATP, which is synthesized primarily in the mitochondria.  Adenosine 
triphosphate (ATP) supplies the energy required to maintain all body processes. 
The first stage of cell respiration, glycolysis, occurs in the cytosol. Since oxygen 
is not involved, this initial stage is anaerobic.  Although a total of 4 ATP 
molecules are generated, 2 ATP molecules are expended in the formation of two 
molecules of nicotinamide adenine dinucleotide (NADH) as well as the synthesis 
of one molecule of pyruvate.  Pyruvate enters the mitochondrial matrix where it is 
oxidized to acetyl-CoA.  It is within the mitochondrial matrix that the second 
stage, the “citric acid cycle” or “Krebs cycle” takes place.  One glucose molecule 
undergoes a series of oxidation reactions that generate 2 ATP, 6 NADH and 2 
FADH2 upon the completion of the cycle. The first carrier is nicotinamide adenine 
dinucleotide (NAD), which becomes reduced to 6 molecules of NADH.  The 
second carrier is flavin adenine dinucleotide (FAD), which becomes reduced to 
two molecules of FADH2 (Verkhovsky et al., 1996).  These last two products of 
the Krebs cycle (NADH and FADH2) are released from the mitochondrial matrix 
and participate in the last phase of cell respiration, the electron transport chain, 
donating electrons and hydrogen atoms which provide energy for the generation 
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of almost all the ATP required for cell processes by the process of chemiosmosis 
(Babcock and Wikstrom, 1992).  This process creates a proton gradient that 
enables the synthesis of ATP from ADP and phosphate.  Since ATP molecules 
cannot be stored for long periods of time, cellular respiration must constantly 
regenerate ATP.  Each ATP molecule releases 7.3 kilocalories of energy per 
mole (Crofts A, 1996). 
In 1948, Eugene Kennedy and Albert Lehninger discovered that 
mitochondria are the site of oxidation phosphorylation in eukaryotes. Thus began 
the modern study of biological energy transductions.  Mitochondria have two 
membranes.  The outer mitochondrial membrane (OMM) is easily permeable to 
small molecules and ions, which can move freely through transmembrane 
channels formed by !porins!, integral membrane proteins. The inner 
mitochondrial membrane (IMM) is relatively impermeable.  Specific transporters 
are required to traverse the IMM.  Protons cross the membrane as part of 
antiport transport mechanisms, for example Ca++, Fe++, K+, and Na+ (Scheffler, 
2000).   
The mitochondrial respiratory chain contains sequentially acting electron 
carriers, most of which are integral proteins that accept one or two electrons.   
In addition to nicotinamide adenine dinucleotide (NAD) or NADP, other electron 
carriers function in the chain: hydrophobic ubiquinone, which is lipid-soluble and 
cytochromes.  Ubiqunone can accept one or two electrons.  It can freely diffuse 
within the lipid bilayer of the IMM.  Because it can carry both electrons and 
protons, it can couple electron flow to proton flow.  Mitochondria contain three 
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classes of cytochromes: a, b, c, named for differences in their light-absorption 
spectra. 
In the electron transport chain, electrons move from NADH, succinate, 
ubiquinone, cytochromes and eventually to oxygen.  Each carrier down the chain 
is more electronegaive than the preceding carrier. 
The constituents within the inner mitochondrial membrane that perform 
oxidation/reduction reactions are referred to as “complexes”.  The first protein to 
receive two electrons from NADH is NADH dehydrogenase located in Complex I. 
This electron transfer drives the expulsion from the matrix of four protons. A 
mobile carrier called ubiquinone passes the electrons to Complex II, but unlike 
subsequent carriers, ubiquinone does not expel any protons into the space 
between the inner and outer membranes. Succinate (which was synthesized in 
the Krebs cycle) is the only component of the transport chain that takes part in 
both the Krebs cycle and the electron transport chain.  Succinate enters the 
transport chain at Complex II and donates electrons to FAD.  Each passage of 
electrons is accompanied by the expulsion of a proton into the space between 
the membranes.  The electrons are carried from Complex II to Complex III by 
another carrier, cytochrome c.  Cytochrome c is a small, heme-containing soluble 
protein, which freely diffuses within the membrane, carrying one electron from 
Complex II to Complex III. However, unlike the other carriers, cytochrome c 
transports only one electron at a time (Voet and Voet, 2004).     
Some of the hydrogen protons are combined with oxygen at Complex IV, 
producing water.  Oxidation of NADH and FADH2 and the phosphorylation of 
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ADP are coupled by a proton gradient, which has developed across the inner 
membrane.  When electrons are transferred from donor to acceptor through this 
series of protein complexes, the energy released as they flow through the 
transport chain is used to transport protons across the inner membrane, where 
they accumulate in the space between the membranes in a process called 
“chemiosmosis” (Mitchell, 1961).  Chemiosmosis generates potential energy in 
the form of a pH and electrical gradient formed by ions, which pass through the 
large, mushroom-shaped ATP synthase complex sometimes designated 
Complex V. This enzyme completely penetrates the membrane.  The “stem” 
portion of ATP synthase is capable of rotating and with each rotation ADP is 
phosphorylated to ATP (Campbell et al., 2006). The current model of ATP 
synthase (alternating catalytic model) uses the force of movement of protons 
across the inner membrane to drive the synthesis of ATP.  ATP synthase 
undergoes a conformational change, which results from the rotation of one of its 
subunits.  As hydrogen protons enter this structure from an area of high 
concentration to an area of low concentration, the ATP rotator turns, producing 
the energy for the synthesis of ATP from ADP and phosphate.  Thus, energy 
stored in the proton gradient drives the synthesis of ATP from ADP and 
phosphate (Nakamoto et al., 2008). Estimates of the number of protons required 
to synthesize one ATP molecule range from three to four (Voet and Voet, 2004). 
As a result of these oxidation-reduction reactions approximately 36-38 molecules 
of ATP are synthesized.   
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The original model for how complexes are arranged has recently been 
questioned.  The complexes may form supercomplexes or !respirasomes! 
(Heinemeyer et al., 2007).  According to this model, the complexes form 
organized sets of interacting enzymes.  Possibly, this might permit more efficient 
channeling of substrates between complexes.  However, the disagreement over 
these respirasomes is on-going, since some data do not conform to this model 
(Schagger and Pfeiffer, 2000).   
Inhibitors 
 Several common drugs and toxins are known inhibitors of oxidative 
phosphorylation.  An explanation of how some of the more commonly used 
inhibitors affect the respiratory process will aid understanding of some research 
paradigms.  
 Cyanide binds to the iron groups in cytochrome oxidase, thereby inhibiting 
the electron change by halting all oxidation/reduction reactions.  Proton pumps 
cannot function (Illingworth, 2012).  Azide exerts an effect which is similar to 
cyanide.  It binds more strongly than oxygen to cytochrome c oxidase, thereby 
preventing the reduction of oxygen (Tsubaki and Yoshikawa, 1993).   
 Rotenone impairs Complex I by preventing the transfer of electrons from 
Complex I to ubiquinone by blocking its binding site (Lambert and Brand, 2004).  
 The affinity of the electron chain for carbon monoxide is lower than that for 
oxygen.  However, it still exerts a detrimental effect by inhibiting cytochrome 
oxidase (Illingworth, 2012). 
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 Antimycin inhibits the flow of electrons from cytochrome b to cytochrome 
c1 at Complex 3, thus preventing the reduction of cytochrome c and the oxidation 
of both NADH and succinate (Illingworth, 2012). 
 Another disruptor of cell respiration is 2,4-dinitrophenol, which interferes 
with the proton gradient by carrying protons across the inner mitochondrial 
membrane, thereby uncoupling proton pumping from the synthesis of ATP 
(Heytler, 1979).  
 Oligomycin is an antibiotic which binds to ATP synthase, the last enzyme 
in the electron transport chain, thus preventing State III respiration.  State III is 
defined as ADP-stimulated respiration.  As energy in the electrical gradient is 
used up, ADP binds to ATP synthase.  In the presence of inorganic phosphate, 
which also binds ATP synthase, a channel is opened in the ATP synthase 
complex that allows protons into the matrix from the inner mitochondrial 
membrane.  As energy in the gradient is removed, the electron transport chain 
speeds up, producing more ATP.  Oligomycin blocks the proton channel in the 
ATP synthase, thereby completely preventing STATE III respiration, which 
requires ATP (Joshi and Huang, 1991). The respiratory effects are not 
immediate, but become apparent after several minutes (Joshi and Huang, 1991).  
 Malonate and oxaloacetate are competitive inhibitors of Complex II.  
Malonate inhibits succinate dehydrogenase by binding to its active site without 
reacting and therefore competes with succinate.  Oxaloacetate is also an inhibitor 
of Complex II  (Heytler, 1979). 
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Comparison of Electron Carriers  
 
There are both similarities and dissimilarities between electron carriers 
involved in the respiratory chain and electron carriers in the steroid P450 system.  
Although some enzymes are embedded in the inner mitochondrial membrane, in 
both the respiratory and steroidogenic systems there are small peripheral 
enzymes that act as electron carriers.  It is postulated that this may afford faster 
diffusion of surface proteins in contrast to those within the membrane.  The 
membrane has a high protein content, which may impede electron transport.  For 
example, the diffusion rate of cytochrome c is ten times faster than complexes 
embedded in the membrane (Gupte, et al., 1984).  
Mitochondrial P450 systems bear similarities to the respiratory oxidative 
phosphorylation system in several respects.  The respiratory system is 
composed of four complexes (I-IV), which are embedded in the inner 
mitochondrial membrane.  Cytochrome c is a small protein, which is not 
embedded, but is located on the side of the intermembrane space.  This is also 
true of another small electron transfer protein, ubiquinone, of the respiratory 
transfer system.  All three proteins of the mitochondrial P450 systems are 
integral membrane proteins, whereas adrenodoxin and adrenodoxin reductase 
are mobile and soluble in the matrix (Hanukoglu et al., 1981a, 1981b).  In this 
regard, therefore, they may be compared to cytochrome c and ubiquinone of the 
respiratory transfer chain. 
Electron transfers between Complex III and Complex IV are mediated by 
cytochrome c.  Transfers between Complex I, II, and III are mediated by 
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ubiquinone, another small protein.  Since cytochrome c binds both to its 
reductase on Complex III and oxidase on Complex IV it must be capable of 
moving between the two complexes.  In this regard, cytochrome c in the 
respiratory chain behaves in a similar manner to adrenodoxin in the 
steroidogenic system.  Both are capable of movement and are not, therefore, 
integral components of the membrane  (Capaldi, 1982 and Gupte et al., 1984). 
 Since oxidative phosphorylation enzymes and steroidogenic enzyme 
levels increase in concert, it seems likely that their regulation is correlated.  This 
is understandable, since increased steroid synthesis necessitates an increase in 
the requirement for energy.  
Reactive Oxygen Species (ROS)  
 Reactive oxygen species are generated during cellular respiration and 
steroidogenesis. 
 Electron transfer may be “coupled” (all electrons from NADPH used to 
hydroxylize the substrate) or “leaky” (some electrons transferred to oxygen).  In 
the latter instance, oxygen radicals are generated as a result of the amount of 
NADPH oxidized exceeding the amount of substrate hydroxylated.  The reactivity 
of these oxygen radicals is due to their unpaired valance electrons.  Experiments 
have shown that P450 proteins can oxidize NADPH even when steroid substrate 
is not present (Rapoport et al., 1995). Since NADPH is required for many 
reactions within the mitochondria in addition to its role in the respiratory transport 
chain, a basal level is necessary for normal cell function.  It appears, therefore, 
that the creation of oxygen radicals is unavoidable.  Oxygen is the acceptor of 
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leaky, uncoupled electrons, producing a superoxide radical (Hanukoglu et al., 
1993).  Two superoxide radicals are able to react with two protons, producing 
hydrogen peroxide in a reaction termed a “dismutation”.  Hydrogen peroxide may 
be converted to benign substances such as oxygen and water by catalase and 
superoxide dismutase.  However, it is likely that some peroxides will persist in the 
cell. The leakage of electrons from mitochondria during the respiratory electron 
transfer chain is the primarily source of these reactive oxygen radicals (ROS), 
(Genova et al., 2003).    
Cells defend themselves against ROS damage with enzymes such as 
superoxide dismutases, catalases, lactoperoxidases, and small molecule 
antioxidants such as ascorbic acid (vitamin C), tocopherol (vitamin E), uric acid 
and glutathione.  These substances either neutralize or scavenge free radicals 
(Hanukoglu, 2006).   
The deleterious effects of ROS include damage to proteins, lipids and 
DNA.  ROS is generated when cells are actively proliferating and progesterone is 
being synthesized. The generation of free radicals contributes to apoptotic cell 
death, which occurs during luteolysis (Behrmann et al., 2001).  Evidence from 
several sources indicates a decrease in antioxidant levels as the corpus luteum 
regresses, although the results are not consistent (Hanukoglu, 2006).  In addition 
to ROS, there are many other factors involved in luteolysis (Amsterdam et al., 
2003; McCracken et al, 1999). 
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Rationale and Methodology 
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Chapter VI.  Hypothesis and Objectives 
Rationale for Investigating Effects of PGE2 and PGF2!  
 Our investigations have focused on two prostaglandins: PGE2 and PGF2! 
and their effects upon cell respiration and progesterone synthesis.  This choice 
was partially dictated by a literature search, which revealed the complex and 
conflicting influence of these two prostaglandins upon cell respiration and 
steroidogenesis. It is apparent that there is ample ambiguity to justify further 
investigation. The present study has been conducted to clarify the mode of action 
of these two prostaglandins in bovine corpora lutea.  It is noteworthy that we 
have found no mention in the literature of the effect of PGE2 or PGF2! upon 
oxygen consumption of mitochondria isolated from bovine corpora lutea. In view 
of the fact that respiratory distress could contribute to the process of luteolysis, it 
was decided to pursue this avenue in our research. We believe that the current 
study constitutes new, important data on the influence of PGE2 and PGF2! on 
cellular respiration.  
 
Hypothesis 
 The addition of PGE2 or PGF2! to mitochondria obtained from bovine 
corpora lutea will affect oxygen consumption and the secretion of progesterone. 
 
 
 
 
!! "#!
Objectives 
 The overall objectives of this study were: 
1.  To determine the effect of PGF2! or PGE2 on oxygen consumption by 
mitochondria isolated from bovine corpora lutea. 
 
2.  To determine the effect of PGF2! or PGE2 on the synthesis of  
      progesterone by mitochondria isolated from bovine corpora lutea.
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Chapter VII.  Materials and Methods 
Mitochondrial Isolation  
 Mitochondria were isolated from firm, well-developed bovine corpora lutea 
obtained from Applied Reproductive Technology, Madison, WI. All procedures 
were carried out at 4°C. Corpora lutea were removed from ovarian tissue, 
minced, and washed with isolation buffer (250 mM sucrose, 1mM EGTA, 10 mM 
Tris, o.1% BSA, and the pH adjusted to 7.4). Following washing, 15 g of minced 
tissue was suspended in 150 ml of isolation buffer and subjected to two 
homogenization processes. The first of these was accomplished in a Kontes 
Duall grinder (Vineland, New Jersey) with several passes, whereas the second 
homogenization was performed using a Wheaton Potter-Elvehjem grinder 
(Millville, New Jersey) with several passes. Pestles for these grinders were 
driven by a heavy-duty drill at 1400 rpm. After homogenization, contents were 
centrifuged for 10 minutes at 3000 rpm (452.5 g) to remove cellular debris. The 
pellet was discarded and the supernatant centrifuged for 10 minutes at 7500 rpm 
(2830 g). After the second centrifugation, the pellet was saved, and washed with 
suspension buffer. The pellet was transferred to an eppendorf tube with 1000 µl 
of suspension buffer (250 mM sucrose, 10 mM HEPES, pH 7.4). Protein content 
was measured using a Bicinchoninic Acid Protein Assay Kit B9643 (Sigma 
Chemical Co, St. Louis MO).  The Bicinchoninic Assay consists of two reagents:  
Reagent A (Sigma B9643) and Reagent B (Sigma C2284).   Reagent A contains 
1 g sodium bicinchoninate, 2 g sodium carbonate, 0.16 g sodium tartrate, 0.4 g 
NaOH, and 0.95 g sodium bicarbonate.  These components were added to 100 
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ml distilled water and adjusted to pH 11.25.  Reagent B contains 0.4 g cupric 
sulfate in 10 ml distilled water.  Reagent A, 100 volumes, is mixed with 2 volumes 
of reagent B.  Samples are read at 562 nm.  This test is based upon the principle 
that complexes between copper ions and peptide bonds will produce a purple 
end product. 
Characterizing Mitochondrial Function 
 In the current investigation, mitochondrial function was characterized 
using oxygen consumption studies and also via staining to visualize outer 
membrane integrity.  
Oxygen Consumption Measurement  
Mitochondrial oxygen uptake was determined using a Clark electrode. The 
Clark electrode operates on the principle that reduction of oxygen will generate a 
current. The current decreases if oxygen consumption increases. Therefore, the 
current is directly proportional to the amount of oxygen in a solution. Oxygen 
consumption was expressed as nanomoles of oxygen consumed per minute per 
mg of mitochondria. The resulting decrease in voltage (mV) was graphed and 
analyzed to determine oxygen consumption.   
The Clark electrode was attached to a water bath maintained at 37 °C and 
connected to a computer and data logger. Incubation buffer provided oxygen to 
the incubation chamber, which was stirred with a 10 mm magnetic bar at 600 
rpm. Oxygen consumption of mitochondria was recorded at pH 7.4 in incubation 
buffer (250 mM sucrose, 5mM KH2PO4, 5mM MgCl2, 0.1 mM EDTA, 0.1% BSA, 
20 mM HEPES). 
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Mitochondrial Staining 
Further verification of the health of the mitochondria and the integrity of 
the outer membrane was obtained by use of a hemocytometer to view 
mitochondria at 440 magnification.  The mitochondria were stained with Janus 
Green B (Ward!s #9458601; 1% aqueous solution), a vital stain, which is the 
preferred stain for mitochondria, since it changes color according to the amount 
of oxygen present. Mitochondria stain blue in its presence, indicating the 
presence of oxygen. Our intention was to verify the presence of healthy 
mitochondria, since the mitochondria stain pink if the membrane is compromised.  
Our diluted solution contained 10 µl mitochondria (14,425 mitochondria), 
10 µl Janus Green B dye, and 80 µl suspension buffer.  The suspension buffer 
consists of 21.4 g sucrose, 0.691 g HEPES at pH 7.4.  Mitochondria were 
observed via the use of a hemocytometer.  The area of each small square = 0.04 
mm3, depth = 0.1 mm.  Area x depth = volume per square.  Volume per square 
multiplied by the number of squares counted = the number of mitochondria per 
mm3.  Lastly, this number is multiplied by the dilution factor.  When oxygen is 
present in the medium, the dye takes on a blue color (Lazarow and Cooperstein, 
1953). 
It is extremely difficult to view mitochondria, whose average size ranges 
from 0.5 to 10 µm and whose numbers are estimated to average 1000 – 2000 
per liver cell  (Marinos and Billet, 1981).  Liver cells contain the greatest number 
of mitochondria, although the number varies greatly depending upon type of cell 
and species.  Our estimate was approximately 1,442.50 mitochondria/µl of 
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suspension buffer and dye (! 100 µl).  The mitochondria were stained a dark 
blue, which facilitated observation.   It was doubly difficult to observe pink 
mitochondria, but it can be stated that there were very few.  The chief value of 
this staining exercise was to verify that the outer membranes of the mitochondria 
were intact.  
Determining the Oxygen Consumption Rate 
Oxygen consumption rate (OCR) was calculated. OCR respiration is 
defined as in vitro oxygen consumption by isolated mitochondria in a substrate 
(frequently succinate) in the absence of ADP or any inhibitors. The rationale for 
determining the OCR is to permit measurement of the rate of electron transport 
when dissolved oxygen is reduced to water.  The significance of oxygen 
reduction is that it removes electrons, allowing the carriers, NADH, which 
donates electrons to Complex I, and FADH2, which donates electrons to 
Complex II, to be re-oxidized. Thus, the electron chain is essentially an energy 
converter that harnesses the flow of electrons to the pumping of hydrogen ions 
across the inner membrane and into the intermembrane space. This separation 
of electrons on one side of the inner membrane and hydrogen ions on the other 
side of the membrane results in an electro-chemical gradient. Damaged 
mitochondria cannot maintain the gradient. Every in vitro preparation will include 
a small proportion of damaged mitochondria.  Such mitochondria are referred to 
as “uncoupled”, since the gradient is no longer coupled to the synthesis of ATP.    
Although damaged, such mitochondria are capable of consuming oxygen but not 
capable of synthesizing ATP. OCR respiration does not exist in vivo, because 
!! ""!
undamaged mitochondria will not halt activity at Complex IV, but continue the 
process to Complex V and the synthesis of ATP. 
The OCR is determined by measuring points on the graph generated by 
the Clark electrode, indicating the decline of millivolts. See Figure 1 for a pictorial 
representation of the graph and the equation used to determine the OCR. 
Progesterone Determination 
Preparation of mitochondria for the steroidogenesis trials was identical to 
the mitochondrial preparation for the respiration trials, as stated in Chapter VII. 
A hydroxylated derivative of cholesterol, 22R-Hydroxycholesterol (Sigma 
HP384) was chosen in preference to cholesterol for our substrate, since it had 
been used successfully in investigations similar to ours (Fitz et al., 1993; Arikan 
and Yigit, 2009).  Hydroxycholesterol is slightly soluble in water, but readily 
soluble in ethanol.  Therefore, 6-7 µl ethanol was added to our protocol.   
Progesterone formation was determined according to Vizcarra et al. 1997.  
Progesterone was quantified using a solid phase RIA (Coat-A-Count 
progesterone kit, Diagnostic Products Corp., Los Angeles, CA). When different 
concentrations of plasma were assayed, concentrations were parallel to the 
standard curve.  
Standardizing the Substrates and Prostaglandin Concentration for Oxygen 
Consumption and Progesterone Determination 
Incubation buffer (1000 µl ! 1 ml) was added to the Clark electrode as our 
control (see page 85 for chemical constituents).  Isolated mitochondria (30 µl; 1.5 
mg/ml ! 45 µg; 1.5mgml) were added to the incubation buffer and allowed to 
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stabilize for one minute. In the incubation medium either PGF2! or PGE2 (0.75 
or 1.0 µM, (final concentration " 3500 pg/ml) was added and the contents 
stabilized for 3 minutes. Succinate (20 µl; 20 mM, final concentration), (Fisher 
S413) was dissolved in distilled water and added after 5 seconds to the Clark 
electrode.  Ten µl of a known respiratory inhibitor, antimycin, (.02 mM, final 
concentration in ethanol) (Sigma A-864), was added after 5 seconds in one or 
two of our trials to ascertain activity of our mitochondria. 
The concentration of antimycin and succinate was based upon that used 
by other investigators.   We were guided by the results of an experiment by 
Bowolaksono (2008), in our choice of 1 µM concentrations for both PGF! and 
PGE2.  Beta Nicotinamide adenine dinucleotide 2# phosphate, NADPH (25 µl; 
1mM, final concentration), (Sigma N6505) was added to our progesterone trials. 
We determined the appropriate molar concentration of our reagents by 
performing an initial experiment (Figure 3). The number of µl of mitochondria 
used in each trial was dependent upon the results of our Bicinchoninic Acid  
(BCA) analysis, which determined the protein content of the mitochondria. 
Statistical Analysis 
 The experimental design was a completely randomized design and the 
data were analyzed using Proc Mixed procedure of SAS using type 3 tests of 
fixed effects. Results were considered significant at p < 0.05. 
 Trials were performed in duplicate and repeated three times in respiration 
experiments.  Trials were performed in duplicate and repeated four times in 
progesterone experiments.  
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Chapter VIII.  Results and Discussion 
Prostaglandin Influence on Oxygen Consumption 
Figure 1 aided our analysis of data in the determination of oxygen 
consumption rate. Two points on the curve just after succinate addition were 
selected and the oxygen consumption rate was calculated using the equation 
shown.  This calculation was performed on 115 graphs from each individual 
experiment and used to support our conclusions regarding the effect of 
succinate, antimycin, and prostaglandins on mitochondrial oxygen consumption. 
Additional details pertaining to oxygen consumption are illustrated in 
Figure 2. This experiment was repeated a minimum of ten times. Incubation 
buffer was added to the Clark electrode and allowed to stabilize for 60 seconds 
prior to the addition of mitochondria. After the addition of mitochondria, a slight 
decrease in voltage (indicative of increased oxygen consumption) was noted.  
The addition of succinate caused an increase in OCR (p < .0001) in the average 
oxygen consumption.  Mean oxygen consumption prior to the addition of 
succinate as measured by mV, was 100.0 ± 0.5 mV compared to 74.5 ± 0.5 mV 
after succinate addition.  Antimycin, a known inhibitor of oxygen consumption, 
was added after 120 seconds.  As time continued, it was clear that oxygen 
consumption was compromised with the addition of antimycin (p < .0001) even 
when a known stimulator (succinate) was added, averaging 96 mV ± 0.5.  The 
drop in voltage as oxygen consumption increased was attributed to the addition 
of succinate, indicating that our mitochondria are viable, as succinate is a known 
stimulator of mitochondrial function.  Antimycin reduced the drop in mV caused 
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by succinate as oxygen consumption decreased, again confirming that our 
mitochondria are functional.  All further data were converted to nanomoles of 
oxygen consumption instead of mV, as in Figure 2. 
The influence PGF2! on OCR from mitochondria isolated from bovine 
corpora lutea is illustrated in Figure 3.  Nanomoles of oxygen consumed per 
minute per mg of mitochondria were significantly increased by the addition of 
succinate, averaging 2 ± 3.5 versus 84 ± 3.5 nm respectively prior to and after 
succinate addition.  PGF2! was added to achieve 0.01 !M PGF2!, which failed 
to inhibit succinate stimulated OCR, averaging 79.0 ± 3.5 nm. However, when 
PGF2! was added to achieve 1 !M or 10 !M PGF2!, OCR was reduced (p < 
.0001) by approximately 50%.  Oxygen consumption was 38.0 ± 3.5 and 36.0 ± 
3.5 nm respectively for 1 !M and 10 !M PGF2! (p < .0001). The addition of 
antimycin to this preparation of mitochondria reduced OCR to control levels. 
Since both prostagandins and antimycin were dissolved in ethanol prior to to 
addition to the media, influence of ethanol on succinate stimulated OCR was 
determined and it was minor. 
Clearly, the addition of PGF2! to these mitochondria was inhibitory and 
reduced OCR, therefore reducing the production of ATP and perhaps the ability 
to produce progesterone.  Since both 1.0 µM and 10 µM PGF2! had similar 
inhibitory effects on OCR, further experiments used 0.75 µM and 1.0 µM.  
The influence of 0.75 µM and 1.0 µM PGF2! on OCR from mitochondria 
isolated from bovine corpora lutea is depicted in Figure 4.  Succinate stimulated 
OCR was evident in both control treatments, averaging 82.9 ±11.5 nm.  When 
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PGF2! was added at 0.75 µM (p < 0.038) or 1.0 µM (p < 0.047) in the presence 
of succinate, OCR was reduced more than 50%, averaging 46.0 ± 4.0 and 52.0 ± 
8.9 nm respectively for 0.75 µM and 1.0 µM PGF2!.  All molarities of PGF2!, 
0.75 µM, 1.0 µM, and 10 µM (Figures 3 and 4) reduced OCR, indicating that 
luteal cells exposed to PGF2! will not function properly.  Luteolysis caused by 
PGF2! may in part be associated with a direct effect of PGF2! on the luteal cell 
mitochondria. 
The influence of the addition of PGE2 to isolated mitochondria is depicted 
in Figure 5.  Succinate stimulated OCR was evident in both control treatments, 
averaging 82.9 ± 11.8 nm of oxygen consumed per minute per mg of 
mitochondria.  The addition of 30 µl of PGE2 (0.75 µM) in the presence of 
succinate to a similar dispersion of mitochondria significantly (p < 0.021) inhibited 
OCR levels, averaging 38.2 ± 10.2 nm. The addition of 30 µl of PGE2 (1.0 µM) 
also significantly (p < 0.022) inhibited OCR levels, averaging 38.5 nm ±11.8 nm.  
This was surprising, since PGE2 has been implicated as a stimulus of 
progesterone production, which arises from mitochondrial activity. The positive 
influence of PGE2 on luteal function cannot be explained by its negative effect on 
the oxygen consumption of isolated mitochondria. 
Prostaglandin Influence on Progesterone Secretion 
The influence of PGF2! or PGE2 on progesterone production from 
mitochondria isolated from bovine corpora lutea is shown in Figure 6.  22R-
Hydroxycholesterol, at a final concentration of 144 µM, was added as a precursor 
for progesterone production.  The amount of progesterone produced was low and 
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similar across treatments, averaging 94.6 ± 18.7 ng. The addition of 22R-
hydroxycholesterol had a minimal effect on progesterone production, averaging 
93 ± 18.7 ng versus 86.2 ± 18.7 ng respectively for 0 and 144 µM 22R-
hydroxycholesterol.  In this unstimulated model of mitochondrial progesterone 
production, the addition of PGF2! or PGE2 had only minor influences. 
The influence of succinate, which stimulated OCR and electron movement 
in the other experiments, is depicted in Figure 7.  The addition of cholesterol and 
succinate did not improve the amounts of progesterone produced, averaging  
65.9 ± 10.6 ng/ml across all treatments, versus mitochondria alone which 
averaged 84.5 ± 10.6 ng/ml. However, the addition of 30 µl of PGF2! (1 µM) 
decreased progesterone synthesis compared to the control with succinate and 
cholesterol, averaging 46.5 ± 10.6 ng/ml versus 58.1 ± 10.6 ng/ml respectively 
for the 1 µM PGF2! versus 0 µM. Although succinate stimulated electron 
movement in the respiratory electron transport chain, it was ineffective in 
stimulating the synthesis of progesterone. The portion of the mitochondrial inner 
membrane where steroidogenesis occurs was not stimulated by the addition of 
succinate.  The inhibition of progesterone production by PGF2! might be 
associated with its inhibition of oxygen consumption and adverse effect upon 
ATP synthesis.  If mitochondria are deprived of sufficient ATP, there exists the 
possibility of a resulting decrease in progesterone production. 
The low basal progesterone production obtained in the previous 
experiments was unexpected, so the addition of NADPH, an electron donor 
associated with cholesterol metabolism was added to stimulate progesterone 
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production.  The influence of the addition NADPH on progesterone synthesis is 
depicted in Figure 8.  When NADPH was added (1.0 mM) to the protocol, greater 
amounts (p < .0001) of progesterone were produced compared to controls, 
averaging 3100 ± 109.9 for 1.0 mM NADPH versus and 73.3 ± 109.9 for 0.0 mM 
NADPH groups.   
The influence of 30 µl of 0.75 µM or 1.0 µM PGE2 and PGF2! on NADPH 
stimulated progesterone production is depicted in Figures 9, 1f0, 11, and 12.  
NADPH stimulated large amounts of progesterone as seen in Figure 9, averaging 
3448.0 ± 399.0 ng/ml of progesterone in the presence of 1.0 mM NADPH 
compared to 236.4 ± 399.0 ng/ml of progesterone in the absence of NADPH.  
The addition of 0.75 or 1.0 µM PGE2 (Figures 9 and 10) had minimal influence (p 
< 0.7 or 0.9) respectively on progesterone production.  The influence of 0.75 and 
1.0 µM of PGF2! is illustrated in Figure 11.  Clearly, as before, the addition of 
NADPH stimulated (p < 0.0001) large amounts of progesterone.   The addition of 
1.0 µM PGF2! had minimal influence, whereas 0.75 µM reduced (p < 0.04) 
progesterone production by 18%. 
The standard error of the mean associated with NADPH stimulated 
progesterone production was 399.0, which is 10% of the average progesterone 
produced in the positive control treatment.  Variances this large mask treatment 
effects such as the 18% (600.0 ng/ml) drop in progesterone production in the 
0.75 µM PGF2! treatment. To reduce the influence of this variance, 
progesterone values were expressed as a fraction of the average control 
progesterone production and are depicted in Figures 10 and 12.  Nanograms of 
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progesterone produced per ml for each treatment were divided by the average of 
the positive controls and expressed as a fraction prior to statistical analysis. 
In summary, the fraction of progesterone produced was reduced (p < 0.04) 
by the addition of 0.75 µM PGF2! (Figure 12).  The addition of PGF2! reduced 
the fraction of progesterone produced by 28%.  The addition of 1.0 µM PGF2! or 
0.75 and 1.0 µM PGE2 did not significantly influence progesterone production 
(Figures 10 and 12). 
OCR Data 
Crucial to an understanding of luteolysis is the study of those processes 
which impinge upon the viability of the corpus luteum: cell respiration and 
steroidogenesis.  Our in vitro studies on the effect of PGF2! and PGE2 on 
respiration and steroidogenesis in bovine mitochondria have produced some 
results which are similar and other results which differ from conclusions reached 
in in vivo studies. 
The decrease in oxygen consumption by PGF2! would be expected to 
cause a subsequent decrease in ATP production. If the energy needs of the CL 
are compromised, a loss of viability of luteal cells will ensue. What was 
unanticipated about these results was the inhibition of respiration by PGE2 
(Figure 5).    
 Since PGE2 is luteotropic, our results indicating inhibition of oxygen 
consumption were surprising.  However, there is support for inhibition of oxygen 
consumption by PGE2 from other investigations.  Lear et al., 1990, found that 
exogenous PGE2 at a concentration of 30 µM inhibited transport-dependent 
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oxygen consumption in the rabbit kidney by 70% and caused an increase in 
cAMP by approximately 100%. Thus PGE2 may be interfering with the 
phosphorylation of AMP to ATP.  Rainsford (1980) found that PGE2 in a dose of 
0.125 – 1.25 µg/ml inhibited oxygen consumption in rat gastric mucosal slices in 
vitro, thereby reducing the capacity of the mucosa to produce ATP.  
 Both PGE2 (10 -6 g/kg/min) and PGF2! (10 -7 g/kg/min) decreased oxygen 
consumption when infused into the carotids of anesthetized baboons, thus 
providing evidence for the inhibitory effects on oxygen consumption of these two 
prostaglandins in primates (Pickard et al., 1977). 
 Additional support for inhibition of oxygen consumption by PGE2 is 
evident in a study of rat myocardial tissue (Noguchi et al., 2001).  Oxygen 
consumption was reduced in cardiac muscle by the protein kinase C (PKC) 
pathway.  Both PKC and PKA pathways are involved in the metabolism of 
arachidonic acid.  Arachidonic acid has been shown to have a generalized 
inhibitory effect on the sodium/potassium pump, The pump, also called the Na+ - 
K+ - ATPase, maintains the gradients of these ions across the plasma membrane 
via active transport against their concentration gradients.  Therefore, interference 
with the function of the pump results in a diminution of ATP. Investigations 
indicate that inhibition of the pump is primarily due to PGE (Therien and Blostein, 
2000).  It is known that hypoxic conditions adversely affect the generation of 
ATP.  Although the exact mechanism by which PGE exerts its inhibitory effect 
remains unknown, the possibility exists that a decrease in oxygen consumption 
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caused by PGE may explain the multiple inhibitory effects of PGE2 through its 
inhibition of electron transport and reduced ATP production.    
 At a molarity of 0.75 µM, inhibition of oxygen consumption by PGF2! is 
significant at p < .0377 (Figure 4).  This is approximately a 50% reduction.  It is 
evident that this inhibition reduces the amount of ATP available for luteal cell 
activity and could contribute to the luteolytic effects of PGF2!.  A thorough 
search of the literature has failed to disclose any prior investigations on the effect 
of PGF2! on oxygen consumption.  However, it is commonly accepted that 
PGF2! is the primary luteolysin.  Since this study has indicated a significant 
reduction in oxygen consumption by PGF2!, thus impacting ATP synthesis, our 
results support a possible link between depletion of ATP and luteolysis.   
Progesterone Data 
 Cholesterol alone is incapable of stimulating progesterone production in 
this model system (Figure 6.) The addition of succinate (Figure 7) was also 
ineffective in stimulating steroidogenesis. Succinate, although increasing oxygen 
consumption, did not increase progesterone production.  This may be the result 
of a clear separation between electron movement in the ATP transport chain and 
electron movement associated with progesterone synthesis.  The cristae of the 
mitochondrial inner membrane are not identical in arrangement in steroid-
producing tissue and non-steroidal tissue.  The steroidal substructure of the 
lamellar cristae contains a gap between membranes of approximately 4 
nanometers.  This is significant because the size of this gap is not sufficiently 
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large to accommodate one of the subunits of ATP synthase (Prince and 
Scheffler, 2002), thus precluding oxidative phosphorylation.    
 The addition of NADPH (Figure 8) provides the essential component for 
successful steroidogenesis.  The increase in progesterone production is highly 
significant (p < .0001).  NADPH is required to stimulate the chain of events  
which culminate in the synthesis of progesterone.   Stein and Tesone, 1992, 
confirmed that the specific site of the action of NADPH is at the conversion of 
cholesterol to pregnenolone within the mitochondria. The entrance of cholesterol 
is also dependent upon the availability of oxygen and electrons, both of which are 
contributed by NADPH (Sulimovici and Boyd, 1968). Thus NADPH is essential 
for the process of steroidogenesis.   
Many investigations have confirmed that PGF2! inhibits progesterone 
secretion (Conley and Ford, 1989; Pate and Condon, 1989; (Gregoraszczuk and 
Michas, 1999; Juengel et al., 2000; Fitz et al., 1993). There is a common 
consensus that PGF2! decreases progesterone in intact animals (Fitz et al., 
1993; Girsh et al., 1996a; McCracken et al., 1972; Niswender and Nett, 1994). 
PGF2! decreases progesterone from purified preparations of ovine and bovine 
large luteal cells (Wiltbank et al., 1991).  In vivo, very low levels of PGF2! (" 250 
pg/ml) are required to depress progesterone secretion in sheep (McCracken, 
1999). The evidence that PGF2! has an inhibitory effect is substantial.  When 
PGF2! was added to the mitochondria, progesterone production was inhibited 
even in the presence of NADPH. PGF2! inhibited both baseline (Figure 7) and 
NADPH-stimulated progesterone production (Figure 11). PGF2! clearly inhibited 
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the movement of electrons in the ATP transport chain (Figure 4), which might 
have contributed to the inhibition of baseline progesterone production.  In the 
presence of NADPH, which stimulated a 10-fold increase in progesterone 
production, PGF2! reduced progesterone production by 28%, indicating that 
PGF2! was influencing the movement of electrons along the steroidogenic 
transport chain.   
PGF2! decreases the synthesis of progesterone via multiple mechanisms. 
It is speculated that progesterone could be decreased by several intracellular 
events, including down-regulation of receptors, decreased uptake of cholesterol, 
decreased transport of cholesterol across mitochondrial membranes, and 
decreased activity of the enzymes required for the synthesis of progesterone. 
These anti-steroidogenic effects of PGF2! appear to be mediated by the protein 
kinase C secondary messenger pathway (Niswender et al., 2000).  When PGF2! 
binds to receptors on the large luteal cells, a chain of events is set in motion 
which ultimately results in an increase in calcium (Juengel et al., 1996; 
(Abramovitz et al., 1994; Graves et al., 1995).  Calcium promotes the synthesis 
of additional PKC and inhibits synthesis of cholesterol (Niswender et al., 2000; 
(McGuire et al., 1994; Boujrad and Hudson, 1993). The decrease in cholesterol 
may be another of the mechanisms whereby PGF2! inhibits the synthesis of 
progesterone. Confusion results from recent reports that both PGE2 and PGF2! 
at concentrations of 1µM stimulate progesterone synthesis in bovine luteal cells 
in vitro when incubated for 24 hours (Bowolaksono et al., 2008). This result is in 
contrast with our results in Figure 7 and Figure 10.  Also surprising was the 
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conclusion of Bowolaksono et al., that PGE2 and PGF2! exert luteoprotective 
roles by suppressing apoptosis in the large luteal cells. 
In vitro, PGF2! prevents cholesterol from interacting with the side-chain 
enzyme (P450scc), resulting in an initial drop in progesterone in incubated whole 
luteal cells (Grusenmeyer and Pate, 1992).  After this initial drop in progesterone, 
StAR mRNA declines, compounding the loss of progesterone (Pescador et al., 
1996).  The decrease in StAR suppresses the availability of cholesterol, since 
StAR is required for the transfer of cholesterol to the tubular sites of the 
mitochondria where much of the P450scc is located (Jefcoate and Artemenko, 
2004). The decrease in StAR mRNA occurs after the initial drop in progesterone, 
and therefore, fails to explain the initial drop in progesterone synthesis.  Attempts 
to locate the precise site within the luteal cell where PGF! exerts its effects 
continue to be illusive (Pate, 2012).  However, in the present study, PGF2! 
directly influenced the mitochondria in some manner such that less progesterone 
was produced. 
Membrane Permeability and Prostaglandins 
How do prostaglandins diffuse into a luteal cell and influence 
mitochondria? Because of their lipid nature, prostaglandins were originally 
thought to traverse cell membranes by passive diffusion.  Although PGE2 and 
PGF2! are able to pass through membranes by diffusion, diffusion is too slow to 
be suitable for cellular needs.  Since prostaglandins are orgainic anions, they 
traverse membranes inefficiently.  This is the result of the nature of both the 
plasma membrane and the mitochondrial membrane, which both consist of a 
!! "#$!
bilayer of phospholipids. The hydrophilic heads of the phospholipids are exposed 
to the aqueous milieu outside the mitochondrion and the hydrophobic tails   
inside the membrane, apposed to the inner membrane, where the phospholipids 
are similarly arranged.  The externally oriented phosphate heads are negatively 
charged, as are the prostaglandins.  The positioning of these two negative 
charges impedes entrance of negatively charged substances such as 
prostaglandins.  
Prostaglandins typically enter membranes with the aid of receptors and 
transporters.  The mitochondria in our investigation are intact, and therefore the 
mitochondrial membrane would possess receptors. Carrier-mediated transport 
enables prostaglandins to cross cell membranes faster than diffusion (Schuster, 
2002).  Bovine prostaglandin transporter (PGT) assists the entrance and exit of 
both PGE2 and PGF2! with equal affinity.  PGT is involved in transport within the 
bovine uterus and from the uterus to the uterine-ovarian plexus, where the 
prostaglandins primarily affect the large luteal cells (Arosh 2004).  When 
transported to the luteal cell by PGT, both PGE2 and PGF2! enter the cell via G 
protein-coupled receptors.  In the bovine these are primarily PGE2 receptors EP2 
and EP4 and PGF2! receptor FP, which are located on the luteal cell membrane.  
Unfortunately, there is a lack of information regarding the structure of the EP2 
and EP4 receptors  (Regan, 2003).    
Prostaglandins may either bind to luteal cells to exert their effects or be 
synthesized within luteal cells.  However, their influence upon mitochondrial 
function is dependent upon second messengers, since PGE2 and PGF2! are 
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excluded from the inner mitochondrial membrane. The outer mitochondrial 
membrane (OMM) contains integral proteins called “porins”.  Porins form 
channels 2-3 nm in diameter, which permit molecules of 5000 Daltons or less to 
freely diffuse across the membrane (Alberts et al.1994).  Since the inner 
mitochondrial membrane is devoid of porins, ions and molecules require 
transporters (Alberts et al., 1994).  These transporter proteins allow the 
membrane to be selectively permeable to small molecules such as ATP. 
Mitochondria and Luteolysis 
Crucial to an understanding of luteolysis is the study of those processes  
which impinge upon the viability of the corpus luteum: cell respiration and 
steroidogenesis.   
 Mitochondria control the corpus luteum in three ways.  They generate 
most of the ATP required by the cell for energy.  They are the site of the initial 
stage of steroidogenesis during which pregnenolone is metabolized to 
progesterone. They release pro-apoptotic proteins that activate a cascade which 
culminates in regression of the CL. 
 The thousands of mitochondria in the average cell generate most of the 
ATP required by the cell for energy.  Deprived of oxygen, cellular respiration will 
cease and the amount of ATP available to the cell will diminish, since oxygen 
functions as the terminal electron acceptor in the process of oxidative 
phosphorylation.  Low oxygen affects not only the energy needs of the cell, but 
adversely affects cultured bovine luteal cells. The processes of cellular 
respiration and steroidogenesis are allied and therefore, these processes are not 
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distinct from each other.  Whatever affects oxygen consumption will affect 
steroidogenesis. In support of this contention is the finding that mitochondria in 
Leydig cells must be actively respiring to support steroidogenesis (Allen et al., 
2006). Pregnenolone, the precursor of progesterone, is inhibited in low oxygen 
conditions, resulting in functional luteolysis (Nishimura et al., 2006).  Both of 
these processes occur on the mitochondrial inner membrane, although in 
separate regions. 
 Structural luteolysis of the CL occurs when the mitochondria release 
apoptotic proteins, such as cytochrome c.  If apoptosis occurs at the appropriate 
time in the ovarian cycle, it is beneficial, causing regression of the CL and the 
initiation of a new cycle.   Luteolysis in ruminants is initiated by the binding of 
PGF2! to its FP receptor on the luteal membrane.  As a result, free calcium is 
released and protein kinase C is activated (PKC). Subsequent events await 
further investigation, but could include PGF2! transport to the mitochondria, a 
decrease in steroidogenic enzymes and a loss of structural integrity of the CL 
(Diaz et al., 2000). 
  The collective results from our experiments verify the luteolytic effects of 
PGF2!.  For the first time, this study has documented the detrimental effects on 
cell respiration of PGF2!, which doubtless contributes to the inhibition of 
steroidogenesis. Our determination of the effect of PGF2! on cellular respiration 
in luteal mitochondria represents new data.  To our knowledge, this study is the 
first to investigate the effect of PGF2! on mitochondrial oxygen consumption in 
ruminants. 
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The mechanism of the role of PGF2! within the corpus luteum remains a 
conundrum (Pate, 2012).  However, the pieces of the puzzle are beginning to 
come together.  The dual processes of cellular respiration and steroidogenesis 
both occur on the inner mitochondrial membrane.  Future studies need to be 
designed to elucidate how both electron transport mechanisms are positioned on 
the membrane and how both PGE2 and PGF2! influence them. 
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Figure 1.  Equation for determination of oxygen consumption rate. 
The Clark electrode communicates with a computer to produce a trace 
similar to the one pictured above.  Analysis of the graphs generated in our 
respiration trials permitted determination of the amount of oxygen consumed.  
Measurements between the points indicated on the graph were factored into the 
equation shown. 
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Figure 2.  Effect of succinate (20 mM) and antimycin (0.02 mM) on oxygen 
consumption rate in mitochondria (1.5 mg/ml) isolated from bovine luteal cells. 
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Figure 3.  Effect of various concentrations of PGF2! (0, 0.01, 1.0, or 10 µM) on 
oxygen consumption in mitochondria (1.5 mg/ml) isolated from bovine luteal cells 
with succinate (20 mM), ethanol (0 µl added to 0 PGF2!, .4 µl added to 0.01 µM 
PGF2!, 40 µl added to 1 µM PGF2!, 400 µl added to 10 µM PGF2!), antimycin 
(0.02 mM)  was added as indicated. 
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Figure 4.  Effect of PGF2! (0.75 and 1.0 µM) on oxygen consumption in 
mitochondria (1.5 mg/ml) isolated from bovine luteal cells with ethanol (30 – 40 
µl), succinate (20 mM) at 37° C.  Control 1 = 30 µl ethanol, mitochondria, 
succinate (20 mM). Control 2 = 40 µl ethanol, mitochondria, succinate (20 mM). 
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Figure 5.  Effect of PGE2 (0.75 and 1 µM) on oxygen consumption in 
mitochondria (1.5 mg/ml) isolated from bovine luteal cells with ethanol (30-40 µl) 
and with succinate (20 mM).  Control 1 = 30 µl ethanol, mitochondria, succinate 
(20 mM). Control 2 = 40 µl ethanol, mitochondria, succinate (20 mM). 
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Figure 6.  Effect of PGE2 and PGF2! (0.75 and 1 µM) on synthesis of 
progesterone from mitochondria (1.5 mg/ml) isolated from bovine luteal cells with 
or without cholesterol (144 µM), and ethanol (6-7 µl). 
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Figure 7.  Effect of PGE2 AND PGF2 ! (0.75, 1 µM) on synthesis of 
progesterone from mitochondria (1.5 mg/ml) isolated from bovine luteal cells with 
or without cholesterol (144 µM), succinate (20 mM), ethanol (6-7 µl) at 37°C. 
 
 
 
Figure 7.  Effect of PGE2 AND PGF2 ! (0.75 and 1 µM) on synthesis of 
progesterone from mitochondria (1.5 mg/ml) isolated from bovine luteal cells with 
or without cholesterol (144 µM), succinate (20 mM), and ethanol (6-7 µl). 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
!! ""#!
 
 
 
 
 
 
 
 
 
Figure 8.  Effect of the addition of NADPH (1mM) on synthesis of progesterone 
in mitochondria (1.5 mg/ml) isolated from bovine luteal cells with cholesterol (144 
µM), succinate (20 mM) and NADPH (1 mM).    
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Figure 9.   Effect of PGE2 (0.75 and 1 µM), antimycin (0.02 mM), cholesterol  
(144 µM), ethanol (6-7 µl), and NADPH (1 mM) on progesterone synthesis in 
mitochondria isolated from bovine luteal cells at 37° C.  Negative control = 
mitochondria, and ethanol; positive control = mitochondria, cholesterol, and 
NADPH expressed as ng/mL. 
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Figure 10.  Effect of PGE2 (0.75 and1 µM), antimycin (0.02 mM), cholesterol  
(144 µM), ethanol (6-7 µl), and NADPH (1 mM) on progesterone synthesis in 
mitochondria isolated from bovine luteal cells at 37° C.  Negative control = 
mitochondria, and ethanol; positive control = mitochondria, cholesterol, NADPH 
expressed as relative value. 
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Figure 11.  Effect of PGF2! (0.75 and 1 µM) on progesterone synthesis in 
mitochondria (1.5 mg/ml) isolated from bovine luteal cells with ethanol (6-7 µl), 
cholesterol (144 µM), NADPH (1 mM), antimycin (0.02 mM) at 37°C.  Negative 
control = mitochondria, and ethanol; postive control = mitochondria, cholesterol, 
and NADPH expressed as ng/mL. 
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Figure 12.  Effect of PGF2! (0.75 and 1 µM) on progesterone synthesis in 
mitochondria (1.5 mg/ml) isolated from bovine luteal cells with ethanol (6-7 µl), 
cholesterol (144 µM), NADPH (1 mM), antimycin (0.02 mM) at 37°C.  Negative 
control = mitochondria, and ethanol; positive control = mitochondria, cholesterol, 
NADPH expressed as relative value. 
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